<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Neurodev Disord</journal-id>
<journal-id journal-id-type="iso-abbrev">J Neurodev Disord</journal-id>
<journal-title-group>
<journal-title>Journal of Neurodevelopmental Disorders</journal-title>
</journal-title-group>
<issn pub-type="ppub">1866-1947</issn>
<issn pub-type="epub">1866-1955</issn>
<publisher>
<publisher-name>BioMed Central</publisher-name>
<publisher-loc>London</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27980692</article-id>
<article-id pub-id-type="pmc">5137220</article-id>
<article-id pub-id-type="publisher-id">9176</article-id>
<article-id pub-id-type="doi">10.1186/s11689-016-9176-3</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Wnt signaling networks in autism spectrum disorder and intellectual disability</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Kwan</surname>
<given-names>Vickie</given-names>
</name>
<address>
<email>kwanv2@mcmaster.ca</email>
</address>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Unda</surname>
<given-names>Brianna K.</given-names>
</name>
<address>
<email>undabk@mcmaster.ca</email>
</address>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Singh</surname>
<given-names>Karun K.</given-names>
</name>
<address>
<email>singhk2@mcmaster.ca</email>
</address>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<aff id="Aff1">Department of Biochemistry and Biomedical Sciences, Stem Cell and Cancer Research Institute, McMaster University, Hamilton, Ontario L8S 4K1 Canada </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>5</day>
<month>12</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>5</day>
<month>12</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="collection">
<year>2016</year>
</pub-date>
<volume>8</volume>
<elocation-id>45</elocation-id>
<history>
<date date-type="received">
<day>30</day>
<month>6</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>7</day>
<month>11</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s). 2016</copyright-statement>
<license license-type="OpenAccess">
<license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<sec>
<title>Background</title>
<p>Genetic factors play a major role in the risk for neurodevelopmental disorders such as autism spectrum disorders (ASDs) and intellectual disability (ID). The underlying genetic factors have become better understood in recent years due to advancements in next generation sequencing. These studies have uncovered a vast number of genes that are impacted by different types of mutations (e.g., de novo, missense, truncation, copy number variations).</p>
</sec>
<sec>
<title>Abstract</title>
<p>Given the large volume of genetic data, analyzing each gene on its own is not a feasible approach and will take years to complete, let alone attempt to use the information to develop novel therapeutics. To make sense of independent genomic data, one approach is to determine whether multiple risk genes function in common signaling pathways that identify signaling “hubs” where risk genes converge. This approach has led to multiple pathways being implicated, such as synaptic signaling, chromatin remodeling, alternative splicing, and protein translation, among many others. In this review, we analyze recent and historical evidence indicating that multiple risk genes, including genes denoted as high-confidence and likely causal, are part of the Wingless (Wnt signaling) pathway. In the brain, Wnt signaling is an evolutionarily conserved pathway that plays an instrumental role in developing neural circuits and adult brain function.</p>
</sec>
<sec>
<title>Conclusions</title>
<p>We will also review evidence that pharmacological therapies and genetic mouse models further identify abnormal Wnt signaling, particularly at the synapse, as being disrupted in ASDs and contributing to disease pathology.</p>
</sec>
</abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>Autism spectrum disorders</kwd>
<kwd>ASD</kwd>
<kwd>Synapse</kwd>
<kwd>Wnt signaling</kwd>
<kwd>GSK3</kwd>
<kwd>Neurodevelopment</kwd>
<kwd>Signaling</kwd>
<kwd>Plasticity</kwd>
<kwd>Mutations</kwd>
<kwd>Neurotransmission</kwd>
<kwd>Neurogenesis</kwd>
<kwd>Neuronal migration</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000038</institution-id>
<institution>Natural Sciences and Engineering Research Council of Canada</institution>
</institution-wrap>
</funding-source>
</award-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000096</institution-id>
<institution>Scottish Rite Charitable Foundation of Canada</institution>
</institution-wrap>
</funding-source>
</award-group>
<award-group>
<funding-source>
<institution>Brain Canada</institution>
</funding-source>
</award-group>
<award-group>
<funding-source>
<institution>JP Bickell Medical Foundation</institution>
</funding-source>
</award-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000874</institution-id>
<institution>Brain and Behavior Research Foundation</institution>
</institution-wrap>
</funding-source>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© The Author(s) 2016</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1">
<title>Background</title>
<sec id="Sec2">
<title>The emerging genetic landscape of Wnt signaling in ASDs</title>
<p>ASDs and other psychiatric disorders may have heritability estimates greater than 90% [<xref ref-type="bibr" rid="CR1">1</xref>], suggesting a strong genetic component to disease. With this background in mind, there has been an enormous advancement of new genetic technologies to discover risk-causing genes and loci. These developments paired with an increased ability to process large data sets have led to many new risk genes being discovered. The number of genes and chromosomal loci linked to ASDs is growing, making it difficult to determine which one(s) to study. This has inspired the field to determine if there are links between the genes and whether they converge into signaling networks important for proper brain development. While the spectrum of ASDs is reflected by the multiple individual risk genes and loci, there is some common denominator between affected individuals, which strongly suggests that disruption of the core neurodevelopmental signaling pathways leads to disease symptoms. In this review, we will examine accumulating evidence for the involvement of Wnt signaling in developmental cognitive disorders. This includes emerging genetic data from large sequencing studies, clinically used medications, and mouse models. We will also present potential avenues for therapeutic approaches, and how Wnt signaling may be modulated for treatment of patient symptoms by leveraging clinical trial data from other fields.</p>
</sec>
<sec id="Sec3">
<title>Making sense of genetic findings</title>
<p>It is no surprise that the clinical heterogeneity of ASDs can be explained, at least in part, by the large number of genetic mutations found through next-generation sequencing. The number of mutations discovered ranges in the several hundreds, according to well-known sources such as the Simons Foundation Autism Research Initiative (SFARI). There is much difficulty in trying to understand the biological etiology of ASDs when so many genes are involved. One hypothesis is that the genetic lesions disrupt specific signaling pathways during discrete time points of brain development. For example, many of the initial genetic studies identified genes involved in synapse development and refinement. This was largely based on findings that multiple genes in syndromic forms of ASDs (e.g., Fragile X syndrome (<italic>FMR1</italic>), Rett syndrome (<italic>MECP2</italic>), Angelman syndrome (<italic>UBE3A</italic>), and genes that cause non-syndromic forms of ASDs (e.g., the Shank and neuroligin/neurexin family of proteins) have important roles during synapse development and refinement [<xref ref-type="bibr" rid="CR2">2</xref>–<xref ref-type="bibr" rid="CR8">8</xref>]. This suggests that the disruption of postnatal synaptic maturation could increase the risk for developing ASDs and related disorders. However, there has been accumulating evidence that other brain developmental milestones are also vulnerable, such as prenatal brain development (e.g., neurogenesis) [<xref ref-type="bibr" rid="CR9">9</xref>], or postnatal development of non-neuronal cells (e.g., oligodendrocytes during myelination and microglia function) [<xref ref-type="bibr" rid="CR10">10</xref>–<xref ref-type="bibr" rid="CR13">13</xref>]. This is also supported by the implication of discrete cell types in the brain based on the identification of specific risk genes expressed in those cells (e.g., inhibitory neurons) [<xref ref-type="bibr" rid="CR14">14</xref>–<xref ref-type="bibr" rid="CR16">16</xref>]. In the current review, we take an alternative approach that is not in contrast to these hypotheses but examines whether there is convergence of multiple risk genes onto specific signaling pathways, which ultimately impact multiple cell types and/or developmental processes. We put forth the notion that by focusing on a specific pathway and dissecting which molecular players in that pathway are important for disease pathophysiology, it may offer an opportunity to identify key proteins to be pharmacologically targeted by drug therapies to treat these disorders.</p>
</sec>
</sec>
<sec id="Sec4">
<title>Review</title>
<sec id="Sec5">
<title>Convergent evidence for Wnt signaling</title>
<p>One pathway highlighted in the multitude of genetic studies is the Wingless (Wnt) signaling. This pathway is highly studied and conserved from lower to higher organisms, where it plays a variety of roles in almost all tissues. Broadly speaking, Wnt signaling in the brain can be divided into two main pathways: (i) “canonical” signaling that results in the stabilization of the protein β-catenin (encoded by <italic>CTNNB1</italic>), which upon stabilization, can exert functions at the plasma membrane or in the nucleus and can act as a transcription factor that modulates the expression of target genes (Fig. <xref ref-type="fig" rid="Fig1">1</xref>); and (ii) “non-canonical” β-catenin-independent signaling [<xref ref-type="bibr" rid="CR17">17</xref>]. Interestingly, many of the proteins in both signaling pathways localize to the synapse and play important functions in synaptic growth and maturation [<xref ref-type="bibr" rid="CR18">18</xref>–<xref ref-type="bibr" rid="CR23">23</xref>]. There are now multiple lines of evidence implicating this pathway in the etiology and pathophysiology of ASD and intellectual disability (ID). While the human genetic data is an important supporting factor, it is not the only one. There are a number of mouse genetic knockout (KO) models targeting Wnt signaling molecules, describing molecular, cellular, electrophysiological, and behavioral deficits that are consistent with ASD and ID. Furthermore, the genes involved in Wnt signaling are of significant clinical interest because there are a variety of approved drugs that either inhibit or stimulate this pathway.<fig id="Fig1"><label>Fig. 1</label><caption><p>Summary of genetic and pharmacological evidence implicating Wnt signaling in developmental cognitive disorders. This diagram depicts the canonical Wnt signaling pathway which consists of Wnt binding to the Frizzled-LRP5/6 co-receptor complex and inhibiting the disassembly of the destruction complex which results in stabilized β-catenin levels, translocation to the nucleus, and initiation of Wnt-dependent gene transcription. Several genes in the canonical Wnt pathway are also identified as high-risk genes associated with autism and intellectual disability (<italic>CHD8</italic>, <italic>DDX3X</italic>, and <italic>TCF4</italic>). Furthermore, listed are a number of pharmacological agents and drugs that target Wnt signaling molecules and can modulate the pathway. Many of the genes listed are shared between different upstream ligand-receptor pathways</p></caption><graphic id="MO1" xlink:href="11689_2016_9176_Fig1_HTML"></graphic></fig>
</p>
</sec>
<sec id="Sec6">
<title>Genetic evidence implicating Wnt signaling genes and support by cellular models</title>
<sec id="Sec7">
<title>CHD8</title>
<p>The strongest single candidate gene for non-syndromic ASDs is chromodomain helicase DNA binding protein 8 (CHD8) [<xref ref-type="bibr" rid="CR24">24</xref>–<xref ref-type="bibr" rid="CR30">30</xref>]. There are multiple de novo, truncating, or missense mutations discovered in <italic>CHD8</italic> in individuals with ASDs [<xref ref-type="bibr" rid="CR27">27</xref>–<xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR31">31</xref>–<xref ref-type="bibr" rid="CR34">34</xref>]. CHD8 is found at active transcription sites with histone modifications H3K4me3 or H3K27ac, and it is thought to directly activate genes by binding near the transcriptional start site and promoting transcription factor activity or recruitment. It can also indirectly impact transcription by interacting with modified histone sites and other co-regulators to make chromatin more assessable [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR34">34</xref>–<xref ref-type="bibr" rid="CR36">36</xref>]. Interestingly, one of the major pathways regulated by CHD8 is canonical Wnt signaling [<xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR38">38</xref>]. Previous work characterized CHD8 as a negative regulator of canonical Wnt signaling, which fits with the hypothesis that elevated canonical Wnt signaling activity causes excessive proliferation of embryonic neural progenitor cells (NPCs) in the brain and may in part explain the macrocephaly (“big brain”) phenotype observed in patients [<xref ref-type="bibr" rid="CR27">27</xref>]. Furthermore, recent studies in human neural progenitors lacking one copy of <italic>CHD8</italic> support this notion, as it revealed many target genes controlled by CHD8 that are involved in the regulation of spine head size [<xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR40">40</xref>]. However a recent study discovered that CHD8 is in fact a positive regulator of Wnt/β-catenin signaling NPCs, while simultaneously demonstrating that it negatively regulates the pathway in non-neuronal cell lines [<xref ref-type="bibr" rid="CR41">41</xref>]. Given this unexpected finding, this suggests that CHD8 regulates Wnt signaling in a cell-specific manner, and the possibility that some of the <italic>CHD8</italic> mutations may not be as simple as loss-of-function for Wnt signaling. Further work is needed to clarify how CHD8 regulates Wnt signaling in different cell types in the brain, and how patients with <italic>CHD8</italic> mutations acquire macrocephaly. It is also important to note that Wnt signaling is only one neurodevelopmental pathway regulated by CHD8, and recent studies have identified many others (e.g., chromatin remodeling). Therefore, future work needs to determine the precise mechanisms and time points during which CHD8 regulates Wnt signaling during neurodevelopment. This is important to better comprehend how prenatal brain development could be compromised in individuals with <italic>CHD8</italic> mutations.</p>
</sec>
<sec id="Sec8">
<title>CTNNB1 (β-catenin)</title>
<p>β-catenin is a central player in the canonical Wnt signaling pathway and works with co-factors to initiate Wnt-dependent gene transcription (Fig. <xref ref-type="fig" rid="Fig1">1</xref>). It has directly been implicated in ASDs due to the identification of de novo mutations in the <italic>CTNNB1</italic> gene in patients with ASD using exome sequencing [<xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR42">42</xref>]. Given the core nature of this gene in canonical Wnt signaling, this strongly places aberrations in Wnt signaling as one of the main networks in ASD pathogenesis. Network analysis from gene expression data also indicates that β-catenin exists in a protein network, including CHD8 and other ASD or ID associated genes [<xref ref-type="bibr" rid="CR25">25</xref>]. The relationship between Wnt signaling and chromatin remodeling factors demonstrates that proper interplay between these pathways is important for appropriate levels of canonical Wnt-dependent gene transcription. CHD8 regulates β-catenin-mediated canonical Wnt signaling, which could occur by CHD8 directly by binding to β-catenin or indirectly by inhibiting the recruitment of co-factors required for transcription at promoter sequences. Future work will need to determine precisely which neural progenitor sub-populations are most sensitive to disruptions in canonical Wnt/β-catenin signaling during prenatal brain development. For example, previous studies indicated that global stabilization of β-catenin in the cortex, which elevates canonical Wnt signaling, leads to brain overgrowth due to increased cycling neural progenitor cells and production of neurons [<xref ref-type="bibr" rid="CR43">43</xref>]. In contrast, deletion of β-catenin from parvalbumin-expressing inhibitory neurons leads to ASD-like defects in neuronal activation and behavior, such as social interaction and object recognition impairments [<xref ref-type="bibr" rid="CR44">44</xref>].</p>
<p>β-caxtenin also functions in pathways other than canonical Wnt signaling, such as cell adhesion at the plasma membrane. β-catenin interacts with cadherins to regulate dendritic spine growth and synaptic competition during the process of postnatal period of dendritic pruning [<xref ref-type="bibr" rid="CR45">45</xref>]. A recent study identified that dominant mutations in <italic> CTNNB1 </italic>from ID patients when expressed in mice have a reduced affinity for membrane-associated cadherins [<xref ref-type="bibr" rid="CR46">46</xref>]. This is associated with a decrease in cadherin interaction and decreased intrahemispheric connections, with deficits in dendritic branching, long-term potentiation, and cognitive function [<xref ref-type="bibr" rid="CR46">46</xref>]. Therefore, it is possible that mutations in β-catenin could lead to aberrant Wnt signaling developmentally, concurrent with disruption of plasma membrane signaling at synaptic sites, both leading to disrupted gene transcription programs and abnormal synaptic plasticity. Furthermore, both of these pathogenic events would increase disease risk. In this regard, these pathways are also likely connected given that β-catenin signaling at the membrane impacts nuclear Wnt-dependent transcription [<xref ref-type="bibr" rid="CR47">47</xref>].</p>
</sec>
<sec id="Sec9">
<title>PTEN</title>
<p>Another high-risk autism candidate gene that has roles in Wnt signaling is <italic>PTEN</italic> due to the discovery of numerous individuals with mutations [<xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR48">48</xref>–<xref ref-type="bibr" rid="CR50">50</xref>]. PTEN has multiple functions but is best known for its role as a negative regulator of the PI3K-Akt-mTOR pathway. Individuals with heterozygous mutations in <italic> PTEN</italic> are also at risk for macrocephaly, indicating that PTEN regulates brain size, which is thought to be an impact on certain individuals with ASD [<xref ref-type="bibr" rid="CR51">51</xref>–<xref ref-type="bibr" rid="CR59">59</xref>]. Multiple mouse models of <italic>Pten</italic> have further strengthened the notion that it is an important regulator of different neural circuits associated with ASDs and cognition. For example, an early study identified that global <italic>Pten</italic> +/- mice have impairments in social interaction behaviors [<xref ref-type="bibr" rid="CR52">52</xref>]. Knocking out <italic>Pten</italic> in the cerebellar Purkinje cells led to impaired sociability, repetitive behavior, and deficits in motor learning. Additionally, knocking out <italic>Pten</italic> in a subset of cortical excitatory neurons results in profound synaptic signaling changes [<xref ref-type="bibr" rid="CR60">60</xref>], while ASD-associated <italic>Pten</italic> alleles expressed in inhibitory neurons cause excitatory/inhibitory imbalances [<xref ref-type="bibr" rid="CR54">54</xref>]. Interestingly, PTEN has recently been identified to function with β-catenin to regulate normal brain growth, implicating PTEN in Wnt signaling. It was discovered that β-catenin signaling is elevated in a mouse model of <italic>Pten</italic> (<italic>Pten</italic> +/-), and a heterozygous mutation in <italic>β-catenin</italic> suppresses the excessive cortical brain growth in <italic>Pten</italic>
<italic>+/-</italic> mice [<xref ref-type="bibr" rid="CR53">53</xref>]. This indicates that multiple ASD risk factors likely converge upon neural progenitor proliferation during embryonic brain development, potentially through regulation of canonical Wnt signaling.</p>
</sec>
<sec id="Sec10">
<title>TCF7L2 (TCF4)</title>
<p>Recent studies have identified mutations in <italic>CTNNB1</italic> within individuals with developmental delay and ID who do not have an ASD [<xref ref-type="bibr" rid="CR46">46</xref>, <xref ref-type="bibr" rid="CR61">61</xref>, <xref ref-type="bibr" rid="CR62">62</xref>]. Additional support comes from another ASD exome sequencing study that identified de novo loss of function variants in <italic>TCF7L2 </italic>(transcription factor 7-like 2 (T-cell specific, HMG-box)) [<xref ref-type="bibr" rid="CR63">63</xref>, <xref ref-type="bibr" rid="CR64">64</xref>], which also goes by the name <italic>TCF4</italic>, and is confused with transcription factor 4 (TCF4) as they share the same symbol. Importantly, TCF7L2 is a key player in canonical Wnt signaling as it helps to initiate gene transcriptional response when Wnt ligands bind their receptors on the membrane, and the signal is transduced to the nucleus (Fig. <xref ref-type="fig" rid="Fig1">1</xref>). These genetic studies directly implicate de novo missense variants in <italic>TCF4</italic> in ASD, suggesting that perturbations to the core canonical signaling complex play a pathogenic role. However, the role of TCF4 in brain development and which time points and cell types it regulates is not well known and needs to be identified in future studies.</p>
</sec>
<sec id="Sec11">
<title>DDX3X</title>
<p>A recent study identified de novo mutations in <italic>DEAD-box helicase 3</italic>
<italic>, X-linked </italic>(<italic>DDX3X</italic>) in a population of unexplained ID [<xref ref-type="bibr" rid="CR65">65</xref>]. DDX3X was identified as a regulator of the Wnt-β-catenin network, via regulation of the kinase activity of CK1ε, to promote phosphorylation of Dvl, both critical factors in canonical Wnt signaling (Fig. <xref ref-type="fig" rid="Fig1">1</xref>). Moreover, in model systems testing the Wnt pathway, DDX3X was found to be required for Wnt-β-catenin signaling in mammalian cells through loss of function studies [<xref ref-type="bibr" rid="CR66">66</xref>]. Therefore, in addition to ASD, Wnt-β-catenin signaling may be disrupted in generalized ID and developmental disorders (DD), further demonstrating the importance of this pathway in proper neurodevelopment. However, a critical question that remains is how do mutations in Wnt signaling molecules give rise to different phenotypes, such as ASD versus ID/DD? This insight would provide tremendous clinical utility, as it will allow caregivers and clinicians to plan therapies according to the future outcome.</p>
</sec>
</sec>
<sec id="Sec12">
<title>Animal models support the involvement of Wnt signaling</title>
<p>Mouse models provide support for Wnt signaling as a clinically relevant pathway for developmental cognitive disorders. First, modeling of high-risk (i.e., causative) ASD genes, for example using gene knockouts (KO), offer the opportunity to determine the neural circuits and brain regions responsible for causing ASD-like behavior. Second, interrogation of other genes in the same pathway, which are not directly involved in ASD from human genetic studies, offers the opportunity to further support that pathway in ASD pathophysiology. For example, while no ASD-specific genetic mutations have been identified in the <italic>disheveled</italic> genes (<italic>Dvl 1, 2 and 3</italic>), <italic>Dvl1</italic> or <italic>Dvl1/3 </italic>KO mice display adult social and repetitive behavioral abnormalities, which are the core features of ASD symptoms [<xref ref-type="bibr" rid="CR67">67</xref>–<xref ref-type="bibr" rid="CR69">69</xref>]. This type of example lends further evidence that perturbation of the core Wnt signaling transduction molecules like Dvl1/3 can result in ASD-like abnormalities even though they are not directly implicated in human genetic studies.</p>
<p>In addition to Dvl1/3, recent studies have highlighted that conditional or complete KO mouse models of other genes involved in Wnt signaling support the pathway being involved in ASD-like phenotypes. One of the best-studied genes is <italic>glycogen synthase kinase 3 </italic>(<italic>GSK3</italic>) α and β, which is a negative regulator of canonical Wnt signaling and also plays important roles directly at the synapse (Fig. <xref ref-type="fig" rid="Fig1">1</xref>). It is well-established that the inhibition of GSK3 using lithium or specific inhibitors (e.g., CHIR 99021) causes an increase in activation of the canonical transcriptional pathway of Wnt signaling [<xref ref-type="bibr" rid="CR70">70</xref>]. <italic>Gsk-3β</italic> heterozygous (+/-) mice display behaviors that resemble wild type (WT) mice treated with lithium, a drug that is used to treat bipolar disorder [<xref ref-type="bibr" rid="CR71">71</xref>], demonstrating that disruption of Wnt signaling leads to behavioral abnormalities. Furthermore, forebrain-specific deletion of <italic>Gsk-3β</italic> in excitatory neurons leads to anxiolytic and pro-social effects [<xref ref-type="bibr" rid="CR72">72</xref>], suggesting that GSK-3β plays important roles in normal behavior. The most convincing evidence that GSK3 and Wnt signaling may be involved in developmental cognitive disorders is its role in Fragile X syndrome (FXS), which is the most commonly inherited form of intellectual disability and is linked to ASDs [<xref ref-type="bibr" rid="CR73">73</xref>, <xref ref-type="bibr" rid="CR74">74</xref>]. Fragile X Mental Retardation Protein (FMRP) KO mice, which is a FXS model, has been shown to possess a dysregulation of GSK3β activity. Specifically, GSK-3β protein and its activity is pathogenically elevated in FXS models [<xref ref-type="bibr" rid="CR75">75</xref>, <xref ref-type="bibr" rid="CR76">76</xref>], and pharmacological correction of this enhanced activity using lithium or GSK3 inhibitors in mice rescues neurobehavioral and brain morphological abnormalities [<xref ref-type="bibr" rid="CR77">77</xref>–<xref ref-type="bibr" rid="CR82">82</xref>]. Furthermore, studies investigating FXS mice demonstrated that Wnt signaling is also disrupted [<xref ref-type="bibr" rid="CR83">83</xref>, <xref ref-type="bibr" rid="CR84">84</xref>]. Of course, GSK-3β has many downstream signaling targets, one of which is the Wnt signaling pathway; demonstrating that modulation of GSK-3β activity can have therapeutic effects beyond the treatment of bipolar disorder.</p>
<p>Another well-studied gene in relation to ASD and psychiatric disorders is <italic>disrupted in schizophrenia 1</italic> (<italic>DISC1</italic>). While the genetic evidence linking DISC1 to developmental cognitive disorders is not strong, the multiple cellular and mouse models of <italic>Disc1</italic> perturbation has led to important findings linking Wnt signaling to abnormal neurodevelopment. For example, a landmark study initially described DISC1 as an inhibitor of GSK-3β, similar to the actions of lithium, demonstrating that DISC1 positively regulates canonical Wnt signaling [<xref ref-type="bibr" rid="CR85">85</xref>], which has been followed up by other studies [<xref ref-type="bibr" rid="CR86">86</xref>–<xref ref-type="bibr" rid="CR89">89</xref>]. Several follow-up studies on multiple mouse models of <italic>Disc1</italic> demonstrate that DISC1 perturbation causes significant neurodevelopmental phenotypes, including cognitive defects and psychiatric-like behavioral manifestations [<xref ref-type="bibr" rid="CR90">90</xref>–<xref ref-type="bibr" rid="CR94">94</xref>].</p>
<p>There are other known regulators of Wnt signaling that when disrupted leads to neurocognitive and neurodevelopmental phenotypes. A recent example is <italic>AnkyrinG </italic>(<italic>Ank3</italic>), which was found to possess a genome-wide significant signal in bipolar disorder [<xref ref-type="bibr" rid="CR95">95</xref>, <xref ref-type="bibr" rid="CR96">96</xref>]. Ank3 is a scaffolding protein that localizes to the nodes of Ranvier in mature neurons, important for the formation and maintenance of the axon initial segment [<xref ref-type="bibr" rid="CR95">95</xref>]. It has also been shown to regulate glutamatergic synapse structure and function through modulation of AMPAR-mediated synaptic transmission and maintenance of dendritic spine morphology [<xref ref-type="bibr" rid="CR97">97</xref>]. Interestingly, Ank3 is a negative regulator of canonical Wnt signaling during embryonic neurogenesis in the mouse brain and functionally interacts with DISC1 to regulate this process [<xref ref-type="bibr" rid="CR46">46</xref>]. <italic>Ank3</italic> heterozygous mice possess behavioral phenotypes such as reduced anxiety and increased motivation for reward, which can be corrected by modulating Wnt signaling through GSK-3β [<xref ref-type="bibr" rid="CR98">98</xref>], demonstrating the clinical involvement of this pathway. In addition to <italic>Ank3</italic>, other recently characterized genes in mice also support a role for Wnt signaling in neurodevelopmental disorders. DIX domain containing 1 (DIXDC1) is a positive regulator of Wnt signaling and neurogenesis through binding to DISC1 [<xref ref-type="bibr" rid="CR99">99</xref>] and a <italic>Dixdc1</italic> KO mouse displayed behaviors associated with neuropsychiatric disorders such as abnormal startle reflex and reduced social interaction [<xref ref-type="bibr" rid="CR100">100</xref>]. The behavioral phenotypes displayed by these mice could be rescued through lithium or GSK3 inhibitor treatment [<xref ref-type="bibr" rid="CR101">101</xref>, <xref ref-type="bibr" rid="CR102">102</xref>].</p>
<p>There are three other Wnt signaling-related genes that have been characterized in mice that lend further support to the involvement of Wnt signaling in developmental cognitive disorders (see Fig. <xref ref-type="fig" rid="Fig1">1</xref>). The first is <italic>adenomatous polyposis coli</italic> (<italic>APC</italic>), which is a critical component of the destruction complex in the canonical Wnt pathway and is important for neural plasticity, learning, and memory in mice. A conditional <italic>Apc</italic> KO mouse showed increased synaptic spine density, elevated frequency of miniature excitatory postsynaptic potentials (mEPSPs), enhanced long-term potentiation (LTP), and ASD-like behaviors (e.g., repetitive behaviors and reduced social interest) [<xref ref-type="bibr" rid="CR103">103</xref>]. Second, analysis of a <italic>Prickle2 </italic>mouse model demonstrates its importance in ASD-related neural circuits and behavior [<xref ref-type="bibr" rid="CR104">104</xref>, <xref ref-type="bibr" rid="CR105">105</xref>]. Prickle2 is a postsynaptic protein that interacts with PSD-95 and is part of the non-canonical Wnt signaling pathway [<xref ref-type="bibr" rid="CR106">106</xref>]. The <italic>Prickle2 </italic>KO mouse has previously been shown to be more sensitive to seizures and also shows reduced dendrite branching, synapse number, and postsynaptic density (PSD) size, as well as behavioral abnormalities (learning abnormalities, altered social interaction, and behavioral inflexibility). Although the involvement of Prickle2 implicates non-canonical Wnt signaling, the phenotypes associated with the KO mouse demonstrate that multiple aspects of Wnt signaling (canonical and non-canonical) are important for the establishment of neural circuits that are disrupted in ASD. While the studies on APC and Prickle2 do not directly implicate abnormal Wnt signaling, we speculate that these mice would have alterations in this pathway due to the importance of these molecules in Wnt signaling in neural cells. Third, a recent study identified that rare missense variants in the <italic>Wnt1</italic> gene discovered in ASD patients show abnormal activation of the Wnt signaling pathway, providing evidence that subtle changes to the coding sequence of Wnt signaling molecules alter biological signaling [<xref ref-type="bibr" rid="CR107">107</xref>]. Together, these studies indicate that when analyzed using animal models, members of the Wnt signaling pathway, which have no link to disease from human genetic studies, demonstrate how disruption of this core signaling pathway in the brain results in developmental phenotypes consistent with human disease.</p>
</sec>
<sec id="Sec13">
<title>Targeting Wnt signaling in ASD/ID mouse models</title>
<p>In addition to animal models, there are two specific drug-induced models that implicate Wnt signaling. The first is valproic acid (VPA), which is thought to increase the risk for ASD through exposure to a pregnant woman during prenatal development [<xref ref-type="bibr" rid="CR108">108</xref>]. The administration of VPA to pregnant mice has long been used as a model of ASD, as the offspring of these mice develop ASD-like deficits in brain structure, neuronal signaling, and behavior [<xref ref-type="bibr" rid="CR109">109</xref>]. VPA has many targets, but one of its better characterized effects is the stimulation of the canonical Wnt signaling pathway through modulation of histone deacetylase and GSK3 [<xref ref-type="bibr" rid="CR110">110</xref>–<xref ref-type="bibr" rid="CR114">114</xref>], demonstrating that abnormal Wnt signaling likely plays an important role in the pathogenicity of VPA. A second model that was recently developed and more specifically implicates Wnt signaling is exposure of pregnant mice to the compound, XAV939, which is a tankyrase inhibitor, resulting in enhanced canonical Wnt signaling [<xref ref-type="bibr" rid="CR115">115</xref>]. This leads to the expansion of the intermediate progenitor cell population in the developing cerebral cortex. The result of exposure to XAV939 is an overpopulation of neurons in the cortex, which disrupts the development and function of dendrites and dendritic spines of excitatory neurons and alters the distribution of interneurons. These mice exhibit ASD-like behavioral abnormalities, implicating that changes to canonical Wnt signaling during prenatal brain development can have a profound impact on brain size and function. These results suggest a causal relationship between abnormal modulation of Wnt signaling during neurodevelopment and autism-like features [<xref ref-type="bibr" rid="CR115">115</xref>].</p>
</sec>
<sec id="Sec14">
<title>Hope for ASD treatment using Wnt signaling modulators?</title>
<p>There is only one FDA approved for ASDs, which is used to treat irritability associated with ASDs (risperidone, an antipsychotic medication), demonstrating the urgent need to find new medications. Many of the medications used are “off-label” (e.g., antidepressants, anticonvulsants, stimulants, and antianxiety medications) and do not treat the core symptoms, and can have very strong side effects. While these medications have multiple modes of molecular action, interestingly, many impact Wnt signaling. For example, haloperidol (typical antipsychotic medication) is known to inhibit dopamine receptors, thereby increasing GSK3β inhibition through Akt activation [<xref ref-type="bibr" rid="CR116">116</xref>], which impacts downstream canonical Wnt signaling [<xref ref-type="bibr" rid="CR117">117</xref>, <xref ref-type="bibr" rid="CR118">118</xref>]. Selective serotonin reuptake inhibitors (SSRIs) (e.g., fluoxetine), which are used to treat depression, potentially by increasing hippocampal neurogenesis in mice, have been shown to antagonize canonical Wnt signaling, which causes a reduction in expression of the serotonin transporter (SERT) in serotonergic raphe neurons through miR-16 [<xref ref-type="bibr" rid="CR119">119</xref>, <xref ref-type="bibr" rid="CR120">120</xref>]. Additionally, lithium is a well-known treatment for bipolar disorder, and one of its main activities is inhibition of GSK-3β, which positively stimulates the canonical Wnt pathway [<xref ref-type="bibr" rid="CR121">121</xref>–<xref ref-type="bibr" rid="CR123">123</xref>]. Stimulants such as Methylphenidate (e.g., Ritalin) can function as a negative regulator of the canonical pathway by activating GSK-3β [<xref ref-type="bibr" rid="CR124">124</xref>, <xref ref-type="bibr" rid="CR125">125</xref>]. In this regard, various GSK-3β inhibitors have been used to rescue neurogenesis defects in mouse models of psychiatric disorders and ASD, which also stimulate canonical Wnt signaling pathways [<xref ref-type="bibr" rid="CR69">69</xref>]. Taken together, while it is important to be cautious of the multiple mechanisms of action of all of the classes of medications discussed here, it is intriguing to find that all of them either directly or indirectly impact canonical Wnt signaling in the brain to some degree. This suggests that abnormal Wnt signaling likely plays a core role in the disease pathogenesis of developmental cognitive disorders, and restoring normal levels of this pathway with medications could be an option for treatment.</p>
<p>Many times the medications tested in pilot clinical trials for neurological disorders are failed drugs from cancer trials. There are many drugs developed and tested as modulators of Wnt signaling in the cancer field that could potentially be repurposed for developmental cognitive disorders. In cases where a reduction in Wnt signaling is thought to underlie the pathology of the disorder, usage of compounds that elevated canonical Wnt signaling could be applied. An example of this is GSK-3β inhibitors that have failed in cancer trials but may be effective for ASDs and ID (e.g., Tideglusig, ClinicalTrials.gov identifier: NCT02586935). In cases where elevated Wnt signaling is thought to contribute to disease pathology, there are many potential options to inhibit canonical Wnt signaling using chemicals (Fig. <xref ref-type="fig" rid="Fig1">1</xref>) that inhibit the interaction between β-catenin and its targets (e.g., inhibiting β-catenin interaction with the TCF factors), disheveled inhibitors (through targeting of the PDZ domain which generally inhibit the Frizzled–PDZ interaction), and tankyrase inhibitors (e.g., XAV939, which induces the stabilization of axin by inhibiting the poly (ADP)-ribosylating enzymes tankyrase 1 and tankyrase 2) [<xref ref-type="bibr" rid="CR126">126</xref>]. These candidate compounds may be of clinical use in cases where it is thought that the genetic risk factor for ASD or ID causes elevated canonical Wnt signaling (e.g., potentially some individuals with CHD8 mutations); however, even if these drugs made it to the clinic, they would likely have to be delivered in utero<italic>,</italic> since embryonic brain development is most affected by such genetic mutations, posing ethical issues for pre-diagnosis therapies.</p>
</sec>
</sec>
<sec id="Sec15">
<title>Conclusions</title>
<p>The goal towards better understanding and treating developmental cognitive disorders is a difficult road and will require a multifaceted research and clinical approach to be successful. In this review, we present evidence that one such signaling pathway that may be central to disease pathogenesis and treatment is the Wnt signaling network. Ongoing and future genetic studies will need to determine the strength of association of this pathway with disease; however, given the medications and drugs that target this pathway currently available, this presents an opportunity for new clinical trials in the near future.</p>
</sec>
</body>
<back>
<glossary>
<title>Abbreviations</title>
<def-list>
<def-item>
<term>ANK3</term>
<def>
<p>AnkyrinG</p>
</def>
</def-item>
<def-item>
<term>APC</term>
<def>
<p>Adenomatous polyposis coli</p>
</def>
</def-item>
<def-item>
<term>ASD</term>
<def>
<p>Autism spectrum disorder</p>
</def>
</def-item>
<def-item>
<term>BP</term>
<def>
<p>Bipolar disorder</p>
</def>
</def-item>
<def-item>
<term>CHD8</term>
<def>
<p>Chromatin-helicase-DNA-binding protein 8</p>
</def>
</def-item>
<def-item>
<term>CIHR</term>
<def>
<p>Chiron</p>
</def>
</def-item>
<def-item>
<term>CTNNB1</term>
<def>
<p>(β-catenin)</p>
</def>
</def-item>
<def-item>
<term>DDX3X</term>
<def>
<p>DEAD-box helicase 3, X-linked</p>
</def>
</def-item>
<def-item>
<term>DISC1</term>
<def>
<p>Disrupted in schizophrenia 1</p>
</def>
</def-item>
<def-item>
<term>DIXDC1</term>
<def>
<p>Dix domain containing 1</p>
</def>
</def-item>
<def-item>
<term>DVL</term>
<def>
<p>Disheveled</p>
</def>
</def-item>
<def-item>
<term>FDA</term>
<def>
<p>Food and drug administration</p>
</def>
</def-item>
<def-item>
<term>FMR1</term>
<def>
<p>Fragile X mental retardation 1</p>
</def>
</def-item>
<def-item>
<term>FMRP</term>
<def>
<p>Fragile X mental retardation protein</p>
</def>
</def-item>
<def-item>
<term>FXS</term>
<def>
<p>Fragile X syndrome</p>
</def>
</def-item>
<def-item>
<term>GSK</term>
<def>
<p>Glycogen synthase kinase</p>
</def>
</def-item>
<def-item>
<term>ID</term>
<def>
<p>Intellectual disability</p>
</def>
</def-item>
<def-item>
<term>KO</term>
<def>
<p>Knockout</p>
</def>
</def-item>
<def-item>
<term>LTP</term>
<def>
<p>Long-term potentiation</p>
</def>
</def-item>
<def-item>
<term>MECP2</term>
<def>
<p>Methyl CpG binding protein 2; miniature excitatory postsynaptic potentials</p>
</def>
</def-item>
<def-item>
<term>mEPSPs</term>
<def>
<p>Miniature excitatory postsynaptic potentials</p>
</def>
</def-item>
<def-item>
<term>NDD</term>
<def>
<p>Neurodevelopmental disorders</p>
</def>
</def-item>
<def-item>
<term>Prickle2</term>
<def>
<p>Prickle planar cell polarity protein 2</p>
</def>
</def-item>
<def-item>
<term>PSD</term>
<def>
<p>Postsynaptic density</p>
</def>
</def-item>
<def-item>
<term>PTEN</term>
<def>
<p>Phosphatase and tensin homolog</p>
</def>
</def-item>
<def-item>
<term>SERT</term>
<def>
<p>Serotonin transporter</p>
</def>
</def-item>
<def-item>
<term>SFARI</term>
<def>
<p>Simons Foundation Autism Research Initiative</p>
</def>
</def-item>
<def-item>
<term>SSRI</term>
<def>
<p>Selective serotonin reuptake inhibitor</p>
</def>
</def-item>
<def-item>
<term>UBE3A</term>
<def>
<p>Ubiquitin-protein ligase E3A</p>
</def>
</def-item>
<def-item>
<term>VPA</term>
<def>
<p>Valproic acid</p>
</def>
</def-item>
<def-item>
<term>Wnt</term>
<def>
<p>Wingless</p>
</def>
</def-item>
<def-item>
<term>WT</term>
<def>
<p>Wild type</p>
</def>
</def-item>
</def-list>
</glossary>
<ack>
<title>Acknowledgements</title>
<p>We would like to acknowledge the following agencies for funding support for research in the laboratory on the topics discussed in this review: NSERC, CIHR, Scottish Rite Charitable Foundation, NARSAD, Brain Canada, and the JP Bickell Foundation.</p>
<sec id="FPar1">
<title>Funding</title>
<p>Financial support for this manuscript was provided by grants from the following agency to Karun Singh: the Natural Sciences and Engineering Research Council, Scottish Rite Charitable Foundation of Canada, JP Bickell Medical Foundation, Brain Canada, and the Brain and Behavior Research Foundation.</p>
</sec>
<sec id="FPar2">
<title>Availability of data and materials</title>
<p>Not applicable.</p>
</sec>
<sec id="FPar3">
<title>Authors’ contributions</title>
<p>The topics of discussion were generated by KKS and VK, and BU assisted KKS in writing the manuscript. VK designed the figures with KKS. All authors read and approved the final manuscript.</p>
</sec>
<sec id="FPar4">
<title>Competing interests</title>
<p>The authors declare that they have no competing interests.</p>
</sec>
<sec id="FPar5">
<title>Consent for publication</title>
<p>Not applicable.</p>
</sec>
<sec id="FPar6">
<title>Ethics approval</title>
<p>Not applicable.</p>
</sec>
</ack>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lichtenstein</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Carlstrom</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Rastam</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gillberg</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Anckarsater</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>The genetics of autism spectrum disorders and related neuropsychiatric disorders in childhood</article-title>
<source/>Am J Psychiatry
          <year>2010</year>
<volume>167</volume>
<issue>11</issue>
<fpage>1357</fpage>
<lpage>63</lpage>
<pub-id pub-id-type="doi">10.1176/appi.ajp.2010.10020223</pub-id>
<pub-id pub-id-type="pmid">20686188</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ebrahimi-Fakhari</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Sahin</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Autism and the synapse: emerging mechanisms and mechanism-based therapies</article-title>
<source/>Curr Opin Neurol
          <year>2015</year>
<volume>28</volume>
<issue>2</issue>
<fpage>91</fpage>
<lpage>102</lpage>
<pub-id pub-id-type="doi">10.1097/WCO.0000000000000186</pub-id>
<pub-id pub-id-type="pmid">25695134</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shepherd</surname>
<given-names>GM</given-names>
</name>
<name>
<surname>Katz</surname>
<given-names>DM</given-names>
</name>
</person-group>
<article-title>Synaptic microcircuit dysfunction in genetic models of neurodevelopmental disorders: focus on Mecp2 and Met</article-title>
<source/>Curr Opin Neurobiol
          <year>2011</year>
<volume>21</volume>
<issue>6</issue>
<fpage>827</fpage>
<lpage>33</lpage>
<pub-id pub-id-type="doi">10.1016/j.conb.2011.06.006</pub-id>
<pub-id pub-id-type="pmid">21733672</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mullins</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Fishell</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Tsien</surname>
<given-names>RW</given-names>
</name>
</person-group>
<article-title>Unifying views of autism spectrum disorders: a consideration of autoregulatory feedback loops</article-title>
<source/>Neuron
          <year>2016</year>
<volume>89</volume>
<issue>6</issue>
<fpage>1131</fpage>
<lpage>56</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2016.02.017</pub-id>
<pub-id pub-id-type="pmid">26985722</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Habela</surname>
<given-names>CW</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Ming</surname>
<given-names>GL</given-names>
</name>
</person-group>
<article-title>Modeling synaptogenesis in schizophrenia and autism using human iPSC derived neurons</article-title>
<source/>Mol Cell Neurosci
          <year>2016</year>
<volume>73</volume>
<fpage>52</fpage>
<lpage>62</lpage>
<pub-id pub-id-type="doi">10.1016/j.mcn.2015.12.002</pub-id>
<pub-id pub-id-type="pmid">26655799</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huber</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Klann</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Costa-Mattioli</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zukin</surname>
<given-names>RS</given-names>
</name>
</person-group>
<article-title>Dysregulation of mammalian target of rapamycin signaling in mouse models of autism</article-title>
<source/>J Neurosci
          <year>2015</year>
<volume>35</volume>
<issue>41</issue>
<fpage>13836</fpage>
<lpage>42</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.2656-15.2015</pub-id>
<pub-id pub-id-type="pmid">26468183</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bourgeron</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>From the genetic architecture to synaptic plasticity in autism spectrum disorder</article-title>
<source/>Nat Rev Neurosci
          <year>2015</year>
<volume>16</volume>
<issue>9</issue>
<fpage>551</fpage>
<lpage>63</lpage>
<pub-id pub-id-type="doi">10.1038/nrn3992</pub-id>
<pub-id pub-id-type="pmid">26289574</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Volk</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Chiu</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Sharma</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Huganir</surname>
<given-names>RL</given-names>
</name>
</person-group>
<article-title>Glutamate synapses in human cognitive disorders</article-title>
<source/>Annu Rev Neurosci
          <year>2015</year>
<volume>38</volume>
<fpage>127</fpage>
<lpage>49</lpage>
<pub-id pub-id-type="doi">10.1146/annurev-neuro-071714-033821</pub-id>
<pub-id pub-id-type="pmid">25897873</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Packer</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Neocortical neurogenesis and the etiology of autism spectrum disorder</article-title>
<source/>Neurosci Biobehav Rev
          <year>2016</year>
<volume>64</volume>
<fpage>185</fpage>
<lpage>95</lpage>
<pub-id pub-id-type="doi">10.1016/j.neubiorev.2016.03.002</pub-id>
<pub-id pub-id-type="pmid">26949225</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pacey</surname>
<given-names>LK</given-names>
</name>
<name>
<surname>Xuan</surname>
<given-names>IC</given-names>
</name>
<name>
<surname>Guan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sussman</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Henkelman</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Thomsen</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Hampson</surname>
<given-names>DR</given-names>
</name>
</person-group>
<article-title>Delayed myelination in a mouse model of fragile X syndrome</article-title>
<source/>Hum Mol Genet
          <year>2013</year>
<volume>22</volume>
<issue>19</issue>
<fpage>3920</fpage>
<lpage>30</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/ddt246</pub-id>
<pub-id pub-id-type="pmid">23740941</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ameis</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Catani</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Altered white matter connectivity as a neural substrate for social impairment in Autism Spectrum Disorder</article-title>
<source/>Cortex
          <year>2015</year>
<volume>62</volume>
<fpage>158</fpage>
<lpage>81</lpage>
<pub-id pub-id-type="doi">10.1016/j.cortex.2014.10.014</pub-id>
<pub-id pub-id-type="pmid">25433958</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Estes</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>McAllister</surname>
<given-names>AK</given-names>
</name>
</person-group>
<article-title>Immune mediators in the brain and peripheral tissues in autism spectrum disorder</article-title>
<source/>Nat Rev Neurosci
          <year>2015</year>
<volume>16</volume>
<issue>8</issue>
<fpage>469</fpage>
<lpage>86</lpage>
<pub-id pub-id-type="doi">10.1038/nrn3978</pub-id>
<pub-id pub-id-type="pmid">26189694</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bilimoria</surname>
<given-names>PM</given-names>
</name>
<name>
<surname>Stevens</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Microglia function during brain development: new insights from animal models</article-title>
<source/>Brain Res
          <year>2015</year>
<volume>1617</volume>
<fpage>7</fpage>
<lpage>17</lpage>
<pub-id pub-id-type="doi">10.1016/j.brainres.2014.11.032</pub-id>
<pub-id pub-id-type="pmid">25463024</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gao</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Penzes</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Common mechanisms of excitatory and inhibitory imbalance in schizophrenia and autism spectrum disorders</article-title>
<source/>Curr Mol Med
          <year>2015</year>
<volume>15</volume>
<issue>2</issue>
<fpage>146</fpage>
<lpage>67</lpage>
<pub-id pub-id-type="doi">10.2174/1566524015666150303003028</pub-id>
<pub-id pub-id-type="pmid">25732149</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marin</surname>
<given-names>O</given-names>
</name>
</person-group>
<article-title>Interneuron dysfunction in psychiatric disorders</article-title>
<source/>Nat Rev Neurosci
          <year>2012</year>
<volume>13</volume>
<issue>2</issue>
<fpage>107</fpage>
<lpage>20</lpage>
<pub-id pub-id-type="pmid">22251963</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nelson</surname>
<given-names>SB</given-names>
</name>
<name>
<surname>Valakh</surname>
<given-names>V</given-names>
</name>
</person-group>
<article-title>Excitatory/inhibitory balance and circuit homeostasis in autism spectrum disorders</article-title>
<source/>Neuron
          <year>2015</year>
<volume>87</volume>
<issue>4</issue>
<fpage>684</fpage>
<lpage>98</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2015.07.033</pub-id>
<pub-id pub-id-type="pmid">26291155</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Salinas</surname>
<given-names>PC</given-names>
</name>
<name>
<surname>Zou</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Wnt signaling in neural circuit assembly</article-title>
<source/>Annu Rev Neurosci
          <year>2008</year>
<volume>31</volume>
<fpage>339</fpage>
<lpage>58</lpage>
<pub-id pub-id-type="doi">10.1146/annurev.neuro.31.060407.125649</pub-id>
<pub-id pub-id-type="pmid">18558859</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Caracci</surname>
<given-names>MO</given-names>
</name>
<name>
<surname>Avila</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>De Ferrari</surname>
<given-names>GV</given-names>
</name>
</person-group>
<article-title>Synaptic Wnt/GSK3beta signaling hub in autism</article-title>
<source/>Neural Plast
          <year>2016</year>
<volume>2016</volume>
<fpage>9603751</fpage>
<pub-id pub-id-type="pmid">26881141</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Purro</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Galli</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Salinas</surname>
<given-names>PC</given-names>
</name>
</person-group>
<article-title>Dysfunction of Wnt signaling and synaptic disassembly in neurodegenerative diseases</article-title>
<source/>J Mol Cell Biol
          <year>2014</year>
<volume>6</volume>
<issue>1</issue>
<fpage>75</fpage>
<lpage>80</lpage>
<pub-id pub-id-type="doi">10.1093/jmcb/mjt049</pub-id>
<pub-id pub-id-type="pmid">24449494</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oliva</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Vargas</surname>
<given-names>JY</given-names>
</name>
<name>
<surname>Inestrosa</surname>
<given-names>NC</given-names>
</name>
</person-group>
<article-title>Wnts in adult brain: from synaptic plasticity to cognitive deficiencies</article-title>
<source/>Front Cell Neurosci
          <year>2013</year>
<volume>7</volume>
<fpage>224</fpage>
<pub-id pub-id-type="doi">10.3389/fncel.2013.00224</pub-id>
<pub-id pub-id-type="pmid">24348327</pub-id>
</element-citation>
</ref>
<ref id="CR21">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stamatakou</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Salinas</surname>
<given-names>PC</given-names>
</name>
</person-group>
<article-title>Postsynaptic assembly: a role for Wnt signaling</article-title>
<source/>Dev Neurobiol
          <year>2014</year>
<volume>74</volume>
<issue>8</issue>
<fpage>818</fpage>
<lpage>27</lpage>
<pub-id pub-id-type="pmid">24105999</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Budnik</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Salinas</surname>
<given-names>PC</given-names>
</name>
</person-group>
<article-title>Wnt signaling during synaptic development and plasticity</article-title>
<source/>Curr Opin Neurobiol
          <year>2011</year>
<volume>21</volume>
<issue>1</issue>
<fpage>151</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1016/j.conb.2010.12.002</pub-id>
<pub-id pub-id-type="pmid">21239163</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Okerlund</surname>
<given-names>ND</given-names>
</name>
<name>
<surname>Cheyette</surname>
<given-names>BN</given-names>
</name>
</person-group>
<article-title>Synaptic Wnt signaling—a contributor to major psychiatric disorders?</article-title>
<source/>J Neurodev Disord
          <year>2011</year>
<volume>3</volume>
<issue>2</issue>
<fpage>162</fpage>
<lpage>74</lpage>
<pub-id pub-id-type="doi">10.1007/s11689-011-9083-6</pub-id>
<pub-id pub-id-type="pmid">21533542</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barnard</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Pomaville</surname>
<given-names>MB</given-names>
</name>
<name>
<surname>O’Roak</surname>
<given-names>BJ</given-names>
</name>
</person-group>
<article-title>Mutations and modeling of the chromatin remodeler CHD8 define an emerging autism etiology</article-title>
<source/>Front Neurosci
          <year>2015</year>
<volume>9</volume>
<fpage>477</fpage>
<pub-id pub-id-type="doi">10.3389/fnins.2015.00477</pub-id>
<pub-id pub-id-type="pmid">26733790</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krumm</surname>
<given-names>N</given-names>
</name>
<name>
<surname>O’Roak</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Shendure</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Eichler</surname>
<given-names>EE</given-names>
</name>
</person-group>
<article-title>A de novo convergence of autism genetics and molecular neuroscience</article-title>
<source/>Trends Neurosci
          <year>2014</year>
<volume>37</volume>
<issue>2</issue>
<fpage>95</fpage>
<lpage>105</lpage>
<pub-id pub-id-type="doi">10.1016/j.tins.2013.11.005</pub-id>
<pub-id pub-id-type="pmid">24387789</pub-id>
</element-citation>
</ref>
<ref id="CR26">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sanders</surname>
<given-names>SJ</given-names>
</name>
</person-group>
<article-title>First glimpses of the neurobiology of autism spectrum disorder</article-title>
<source/>Curr Opin Genet Dev
          <year>2015</year>
<volume>33</volume>
<fpage>80</fpage>
<lpage>92</lpage>
<pub-id pub-id-type="doi">10.1016/j.gde.2015.10.002</pub-id>
<pub-id pub-id-type="pmid">26547130</pub-id>
</element-citation>
</ref>
<ref id="CR27">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bernier</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Golzio</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Xiong</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Stessman</surname>
<given-names>HA</given-names>
</name>
<name>
<surname>Coe</surname>
<given-names>BP</given-names>
</name>
<name>
<surname>Penn</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Witherspoon</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Gerdts</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Baker</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Vulto-van Silfhout</surname>
<given-names>AT</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Disruptive CHD8 mutations define a subtype of autism early in development</article-title>
<source/>Cell
          <year>2014</year>
<volume>158</volume>
<issue>2</issue>
<fpage>263</fpage>
<lpage>76</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2014.06.017</pub-id>
<pub-id pub-id-type="pmid">24998929</pub-id>
</element-citation>
</ref>
<ref id="CR28">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>O’Roak</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Vives</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Girirajan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Karakoc</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Krumm</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Coe</surname>
<given-names>BP</given-names>
</name>
<name>
<surname>Levy</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Ko</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>JD</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations</article-title>
<source/>Nature
          <year>2012</year>
<volume>485</volume>
<issue>7397</issue>
<fpage>246</fpage>
<lpage>50</lpage>
<pub-id pub-id-type="doi">10.1038/nature10989</pub-id>
<pub-id pub-id-type="pmid">22495309</pub-id>
</element-citation>
</ref>
<ref id="CR29">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>O’Roak</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Vives</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Egertson</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Stanaway</surname>
<given-names>IB</given-names>
</name>
<name>
<surname>Phelps</surname>
<given-names>IG</given-names>
</name>
<name>
<surname>Carvill</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Ankenman</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders</article-title>
<source/>Science
          <year>2012</year>
<volume>338</volume>
<issue>6114</issue>
<fpage>1619</fpage>
<lpage>22</lpage>
<pub-id pub-id-type="doi">10.1126/science.1227764</pub-id>
<pub-id pub-id-type="pmid">23160955</pub-id>
</element-citation>
</ref>
<ref id="CR30">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krumm</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Turner</surname>
<given-names>TN</given-names>
</name>
<name>
<surname>Baker</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Vives</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Mohajeri</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Witherspoon</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Raja</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Coe</surname>
<given-names>BP</given-names>
</name>
<name>
<surname>Stessman</surname>
<given-names>HA</given-names>
</name>
<name>
<surname>He</surname>
<given-names>ZX</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Excess of rare, inherited truncating mutations in autism</article-title>
<source/>Nat Genet
          <year>2015</year>
<volume>47</volume>
<issue>6</issue>
<fpage>582</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1038/ng.3303</pub-id>
<pub-id pub-id-type="pmid">25961944</pub-id>
</element-citation>
</ref>
<ref id="CR31">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Neale</surname>
<given-names>BM</given-names>
</name>
<name>
<surname>Kou</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Ma’ayan</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Samocha</surname>
<given-names>KE</given-names>
</name>
<name>
<surname>Sabo</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>CF</given-names>
</name>
<name>
<surname>Stevens</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>LS</given-names>
</name>
<name>
<surname>Makarov</surname>
<given-names>V</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Patterns and rates of exonic de novo mutations in autism spectrum disorders</article-title>
<source/>Nature
          <year>2012</year>
<volume>485</volume>
<issue>7397</issue>
<fpage>242</fpage>
<lpage>5</lpage>
<pub-id pub-id-type="doi">10.1038/nature11011</pub-id>
<pub-id pub-id-type="pmid">22495311</pub-id>
</element-citation>
</ref>
<ref id="CR32">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Talkowski</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Rosenfeld</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Blumenthal</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Pillalamarri</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Chiang</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Heilbut</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ernst</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Hanscom</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Rossin</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Lindgren</surname>
<given-names>AM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Sequencing chromosomal abnormalities reveals neurodevelopmental loci that confer risk across diagnostic boundaries</article-title>
<source/>Cell
          <year>2012</year>
<volume>149</volume>
<issue>3</issue>
<fpage>525</fpage>
<lpage>37</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2012.03.028</pub-id>
<pub-id pub-id-type="pmid">22521361</pub-id>
</element-citation>
</ref>
<ref id="CR33">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McCarthy</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Gillis</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kramer</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lihm</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Yoon</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Berstein</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Mistry</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Pavlidis</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Solomon</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Ghiban</surname>
<given-names>E</given-names>
</name>
<etal></etal>
</person-group>
<article-title>De novo mutations in schizophrenia implicate chromatin remodeling and support a genetic overlap with autism and intellectual disability</article-title>
<source/>Mol Psychiatry
          <year>2014</year>
<volume>19</volume>
<issue>6</issue>
<fpage>652</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1038/mp.2014.29</pub-id>
<pub-id pub-id-type="pmid">24776741</pub-id>
</element-citation>
</ref>
<ref id="CR34">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sugathan</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Biagioli</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Golzio</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Erdin</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Blumenthal</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Manavalan</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Ragavendran</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Brand</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Lucente</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Miles</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>CHD8 regulates neurodevelopmental pathways associated with autism spectrum disorder in neural progenitors</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2014</year>
<volume>111</volume>
<issue>42</issue>
<fpage>E4468</fpage>
<lpage>77</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1405266111</pub-id>
<pub-id pub-id-type="pmid">25294932</pub-id>
</element-citation>
</ref>
<ref id="CR35">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wilkinson</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Grepo</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Thompson</surname>
<given-names>BL</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Evgrafov</surname>
<given-names>OV</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Knowles</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Campbell</surname>
<given-names>DB</given-names>
</name>
</person-group>
<article-title>The autism-associated gene chromodomain helicase DNA-binding protein 8 (CHD8) regulates noncoding RNAs and autism-related genes</article-title>
<source/>Transl Psychiatry
          <year>2015</year>
<volume>5</volume>
<fpage>e568</fpage>
<pub-id pub-id-type="doi">10.1038/tp.2015.62</pub-id>
<pub-id pub-id-type="pmid">25989142</pub-id>
</element-citation>
</ref>
<ref id="CR36">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cotney</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Muhle</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Sanders</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Willsey</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Niu</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Klei</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Lei</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The autism-associated chromatin modifier CHD8 regulates other autism risk genes during human neurodevelopment</article-title>
<source/>Nat Commun
          <year>2015</year>
<volume>6</volume>
<fpage>6404</fpage>
<pub-id pub-id-type="doi">10.1038/ncomms7404</pub-id>
<pub-id pub-id-type="pmid">25752243</pub-id>
</element-citation>
</ref>
<ref id="CR37">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thompson</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Tremblay</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Bochar</surname>
<given-names>DA</given-names>
</name>
</person-group>
<article-title>CHD8 is an ATP-dependent chromatin remodeling factor that regulates beta-catenin target genes</article-title>
<source/>Mol Cell Biol
          <year>2008</year>
<volume>28</volume>
<issue>12</issue>
<fpage>3894</fpage>
<lpage>904</lpage>
<pub-id pub-id-type="doi">10.1128/MCB.00322-08</pub-id>
<pub-id pub-id-type="pmid">18378692</pub-id>
</element-citation>
</ref>
<ref id="CR38">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nishiyama</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Skoultchi</surname>
<given-names>AI</given-names>
</name>
<name>
<surname>Nakayama</surname>
<given-names>KI</given-names>
</name>
</person-group>
<article-title>Histone H1 recruitment by CHD8 is essential for suppression of the Wnt-β-catenin signaling pathway</article-title>
<source/>Mol Cell Biol
          <year>2012</year>
<volume>32</volume>
<issue>2</issue>
<fpage>501</fpage>
<lpage>12</lpage>
<pub-id pub-id-type="doi">10.1128/MCB.06409-11</pub-id>
<pub-id pub-id-type="pmid">22083958</pub-id>
</element-citation>
</ref>
<ref id="CR39">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Pedrosa</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Hrabovsky</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Lachman</surname>
<given-names>HM</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>CRISPR/Cas9-mediated heterozygous knockout of the autism gene CHD8 and characterization of its transcriptional networks in neurodevelopment</article-title>
<source/>Mol Autism
          <year>2015</year>
<volume>6</volume>
<fpage>55</fpage>
<pub-id pub-id-type="doi">10.1186/s13229-015-0048-6</pub-id>
<pub-id pub-id-type="pmid">26491539</pub-id>
</element-citation>
</ref>
<ref id="CR40">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Merner</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Forgeot d’Arc</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Bell</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Maussion</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Gauthier</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Crapper</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Hamdan</surname>
<given-names>FF</given-names>
</name>
<name>
<surname>Michaud</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Mottron</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A de novo frameshift mutation in chromodomain helicase DNA-binding domain 8 (CHD8): a case report and literature review</article-title>
<source/>Am J Med Genet A
          <year>2016</year>
<volume>170</volume>
<issue>5</issue>
<fpage>1225</fpage>
<lpage>35</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.a.37566</pub-id>
</element-citation>
</ref>
<ref id="CR41">
<label>41.</label>
<mixed-citation publication-type="other">Durak O, Gao F, Kaeser-Woo YJ, Rueda R, Martorell AJ, Nott A, Liu CY, Watson LA, Tsai LH. Chd8 mediates cortical neurogenesis via transcriptional regulation of cell cycle and Wnt signaling. Nat Neurosci. 2016.</mixed-citation>
</ref>
<ref id="CR42">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sanders</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Murtha</surname>
<given-names>MT</given-names>
</name>
<name>
<surname>Gupta</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Murdoch</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Raubeson</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Willsey</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Ercan-Sencicek</surname>
<given-names>AG</given-names>
</name>
<name>
<surname>DiLullo</surname>
<given-names>NM</given-names>
</name>
<name>
<surname>Parikshak</surname>
<given-names>NN</given-names>
</name>
<name>
<surname>Stein</surname>
<given-names>JL</given-names>
</name>
<etal></etal>
</person-group>
<article-title>De novo mutations revealed by whole-exome sequencing are strongly associated with autism</article-title>
<source/>Nature
          <year>2012</year>
<volume>485</volume>
<issue>7397</issue>
<fpage>237</fpage>
<lpage>41</lpage>
<pub-id pub-id-type="doi">10.1038/nature10945</pub-id>
<pub-id pub-id-type="pmid">22495306</pub-id>
</element-citation>
</ref>
<ref id="CR43">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chenn</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Walsh</surname>
<given-names>CA</given-names>
</name>
</person-group>
<article-title>Regulation of cerebral cortical size by control of cell cycle exit in neural precursors</article-title>
<source/>Science
          <year>2002</year>
<volume>297</volume>
<issue>5580</issue>
<fpage>365</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1126/science.1074192</pub-id>
<pub-id pub-id-type="pmid">12130776</pub-id>
</element-citation>
</ref>
<ref id="CR44">
<label>44.</label>
<mixed-citation publication-type="other">Dong F, Jiang J, McSweeney C, Zou D, Liu L, Mao Y. Deletion of CTNNB1 in inhibitory circuitry contributes to autism-associated behavioral defects. Hum Mol Genet. 2016. Epub ahead of print.</mixed-citation>
</ref>
<ref id="CR45">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bian</surname>
<given-names>WJ</given-names>
</name>
<name>
<surname>Miao</surname>
<given-names>WY</given-names>
</name>
<name>
<surname>He</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Qiu</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>X</given-names>
</name>
</person-group>
<article-title>Coordinated spine pruning and maturation mediated by inter-spine competition for cadherin/catenin complexes</article-title>
<source/>Cell
          <year>2015</year>
<volume>162</volume>
<issue>4</issue>
<fpage>808</fpage>
<lpage>22</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2015.07.018</pub-id>
<pub-id pub-id-type="pmid">26255771</pub-id>
</element-citation>
</ref>
<ref id="CR46">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tucci</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Kleefstra</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Hardy</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Heise</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Maggi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Willemsen</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Hilton</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Esapa</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Simon</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Buenavista</surname>
<given-names>MT</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Dominant beta-catenin mutations cause intellectual disability with recognizable syndromic features</article-title>
<source/>J Clin Invest
          <year>2014</year>
<volume>124</volume>
<issue>4</issue>
<fpage>1468</fpage>
<lpage>82</lpage>
<pub-id pub-id-type="doi">10.1172/JCI70372</pub-id>
<pub-id pub-id-type="pmid">24614104</pub-id>
</element-citation>
</ref>
<ref id="CR47">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Shemezis</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>McQuinn</surname>
<given-names>ER</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Sverdlov</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Chenn</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>AKT activation by N-cadherin regulates beta-catenin signaling and neuronal differentiation during cortical development</article-title>
<source/>Neural Dev
          <year>2013</year>
<volume>8</volume>
<fpage>7</fpage>
<pub-id pub-id-type="doi">10.1186/1749-8104-8-7</pub-id>
<pub-id pub-id-type="pmid">23618343</pub-id>
</element-citation>
</ref>
<ref id="CR48">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Spinelli</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Black</surname>
<given-names>FM</given-names>
</name>
<name>
<surname>Berg</surname>
<given-names>JN</given-names>
</name>
<name>
<surname>Eickholt</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Leslie</surname>
<given-names>NR</given-names>
</name>
</person-group>
<article-title>Functionally distinct groups of inherited PTEN mutations in autism and tumour syndromes</article-title>
<source/>J Med Genet
          <year>2015</year>
<volume>52</volume>
<issue>2</issue>
<fpage>128</fpage>
<lpage>34</lpage>
<pub-id pub-id-type="doi">10.1136/jmedgenet-2014-102803</pub-id>
<pub-id pub-id-type="pmid">25527629</pub-id>
</element-citation>
</ref>
<ref id="CR49">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Frazier</surname>
<given-names>TW</given-names>
</name>
<name>
<surname>Embacher</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Tilot</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Koenig</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Mester</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Eng</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Molecular and phenotypic abnormalities in individuals with germline heterozygous PTEN mutations and autism</article-title>
<source/>Mol Psychiatry
          <year>2015</year>
<volume>20</volume>
<issue>9</issue>
<fpage>1132</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1038/mp.2014.125</pub-id>
<pub-id pub-id-type="pmid">25288137</pub-id>
</element-citation>
</ref>
<ref id="CR50">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McBride</surname>
<given-names>KL</given-names>
</name>
<name>
<surname>Varga</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Pastore</surname>
<given-names>MT</given-names>
</name>
<name>
<surname>Prior</surname>
<given-names>TW</given-names>
</name>
<name>
<surname>Manickam</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Atkin</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Herman</surname>
<given-names>GE</given-names>
</name>
</person-group>
<article-title>Confirmation study of PTEN mutations among individuals with autism or developmental delays/mental retardation and macrocephaly</article-title>
<source/>Autism Res
          <year>2010</year>
<volume>3</volume>
<issue>3</issue>
<fpage>137</fpage>
<lpage>41</lpage>
<pub-id pub-id-type="doi">10.1002/aur.132</pub-id>
<pub-id pub-id-type="pmid">20533527</pub-id>
</element-citation>
</ref>
<ref id="CR51">
<label>51.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Page</surname>
<given-names>DT</given-names>
</name>
<name>
<surname>Kuti</surname>
<given-names>OJ</given-names>
</name>
<name>
<surname>Prestia</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Sur</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Haploinsufficiency for Pten and Serotonin transporter cooperatively influences brain size and social behavior</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2009</year>
<volume>106</volume>
<issue>6</issue>
<fpage>1989</fpage>
<lpage>94</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0804428106</pub-id>
<pub-id pub-id-type="pmid">19208814</pub-id>
</element-citation>
</ref>
<ref id="CR52">
<label>52.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kwon</surname>
<given-names>CH</given-names>
</name>
<name>
<surname>Luikart</surname>
<given-names>BW</given-names>
</name>
<name>
<surname>Powell</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Matheny</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Baker</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Parada</surname>
<given-names>LF</given-names>
</name>
</person-group>
<article-title>Pten regulates neuronal arborization and social interaction in mice</article-title>
<source/>Neuron
          <year>2006</year>
<volume>50</volume>
<issue>3</issue>
<fpage>377</fpage>
<lpage>88</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2006.03.023</pub-id>
<pub-id pub-id-type="pmid">16675393</pub-id>
</element-citation>
</ref>
<ref id="CR53">
<label>53.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>WC</given-names>
</name>
<name>
<surname>Sejourne</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Clipperton-Allen</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Page</surname>
<given-names>DT</given-names>
</name>
</person-group>
<article-title>Pten mutations alter brain growth trajectory and allocation of cell types through elevated beta-catenin signaling</article-title>
<source/>J Neurosci
          <year>2015</year>
<volume>35</volume>
<issue>28</issue>
<fpage>10252</fpage>
<lpage>67</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.5272-14.2015</pub-id>
<pub-id pub-id-type="pmid">26180201</pub-id>
</element-citation>
</ref>
<ref id="CR54">
<label>54.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vogt</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Cho</surname>
<given-names>KK</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>AT</given-names>
</name>
<name>
<surname>Sohal</surname>
<given-names>VS</given-names>
</name>
<name>
<surname>Rubenstein</surname>
<given-names>JL</given-names>
</name>
</person-group>
<article-title>The parvalbumin/somatostatin ratio is increased in Pten mutant mice and by human PTEN ASD alleles</article-title>
<source/>Cell Rep
          <year>2015</year>
<volume>11</volume>
<issue>6</issue>
<fpage>944</fpage>
<lpage>56</lpage>
<pub-id pub-id-type="doi">10.1016/j.celrep.2015.04.019</pub-id>
<pub-id pub-id-type="pmid">25937288</pub-id>
</element-citation>
</ref>
<ref id="CR55">
<label>55.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Clipperton-Allen</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Page</surname>
<given-names>DT</given-names>
</name>
</person-group>
<article-title>Decreased aggression and increased repetitive behavior in Pten haploinsufficient mice</article-title>
<source/>Genes Brain Behav
          <year>2015</year>
<volume>14</volume>
<issue>2</issue>
<fpage>145</fpage>
<lpage>57</lpage>
<pub-id pub-id-type="doi">10.1111/gbb.12192</pub-id>
<pub-id pub-id-type="pmid">25561290</pub-id>
</element-citation>
</ref>
<ref id="CR56">
<label>56.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Clipperton-Allen</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Page</surname>
<given-names>DT</given-names>
</name>
</person-group>
<article-title>Pten haploinsufficient mice show broad brain overgrowth but selective impairments in autism-relevant behavioral tests</article-title>
<source/>Hum Mol Genet
          <year>2014</year>
<volume>23</volume>
<issue>13</issue>
<fpage>3490</fpage>
<lpage>505</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/ddu057</pub-id>
<pub-id pub-id-type="pmid">24497577</pub-id>
</element-citation>
</ref>
<ref id="CR57">
<label>57.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takeuchi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Gertner</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Parada</surname>
<given-names>LF</given-names>
</name>
<name>
<surname>Bennett</surname>
<given-names>MV</given-names>
</name>
<name>
<surname>Zukin</surname>
<given-names>RS</given-names>
</name>
</person-group>
<article-title>Dysregulation of synaptic plasticity precedes appearance of morphological defects in a Pten conditional knockout mouse model of autism</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2013</year>
<volume>110</volume>
<issue>12</issue>
<fpage>4738</fpage>
<lpage>43</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1222803110</pub-id>
<pub-id pub-id-type="pmid">23487788</pub-id>
</element-citation>
</ref>
<ref id="CR58">
<label>58.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tilot</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Frazier</surname>
<given-names>TW</given-names>
<suffix>2nd</suffix>
</name>
<name>
<surname>Eng</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Balancing proliferation and connectivity in PTEN-associated autism spectrum disorder</article-title>
<source/>Neurotherapeutics
          <year>2015</year>
<volume>12</volume>
<issue>3</issue>
<fpage>609</fpage>
<lpage>19</lpage>
<pub-id pub-id-type="doi">10.1007/s13311-015-0356-8</pub-id>
<pub-id pub-id-type="pmid">25916396</pub-id>
</element-citation>
</ref>
<ref id="CR59">
<label>59.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Parada</surname>
<given-names>LF</given-names>
</name>
</person-group>
<article-title>PTEN signaling in autism spectrum disorders</article-title>
<source/>Curr Opin Neurobiol
          <year>2012</year>
<volume>22</volume>
<issue>5</issue>
<fpage>873</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1016/j.conb.2012.05.004</pub-id>
<pub-id pub-id-type="pmid">22664040</pub-id>
</element-citation>
</ref>
<ref id="CR60">
<label>60.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lugo</surname>
<given-names>JN</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>GD</given-names>
</name>
<name>
<surname>Arbuckle</surname>
<given-names>EP</given-names>
</name>
<name>
<surname>White</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Holley</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Floruta</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Ahmed</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Gomez</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Okonkwo</surname>
<given-names>O</given-names>
</name>
</person-group>
<article-title>Deletion of PTEN produces autism-like behavioral deficits and alterations in synaptic proteins</article-title>
<source/>Front Mol Neurosci
          <year>2014</year>
<volume>7</volume>
<fpage>27</fpage>
<pub-id pub-id-type="doi">10.3389/fnmol.2014.00027</pub-id>
<pub-id pub-id-type="pmid">24795561</pub-id>
</element-citation>
</ref>
<ref id="CR61">
<label>61.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dubruc</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Putoux</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Labalme</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Rougeot</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Sanlaville</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Edery</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>A new intellectual disability syndrome caused by CTNNB1 haploinsufficiency</article-title>
<source/>Am J Med Genet A
          <year>2014</year>
<volume>164A</volume>
<issue>6</issue>
<fpage>1571</fpage>
<lpage>5</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.a.36484</pub-id>
<pub-id pub-id-type="pmid">24668549</pub-id>
</element-citation>
</ref>
<ref id="CR62">
<label>62.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kuechler</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Willemsen</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Albrecht</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Bacino</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Bartholomew</surname>
<given-names>DW</given-names>
</name>
<name>
<surname>van Bokhoven</surname>
<given-names>H</given-names>
</name>
<name>
<surname>van den Boogaard</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Bramswig</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Buttner</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Cremer</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>De novo mutations in beta-catenin (CTNNB1) appear to be a frequent cause of intellectual disability: expanding the mutational and clinical spectrum</article-title>
<source/>Hum Genet
          <year>2015</year>
<volume>134</volume>
<issue>1</issue>
<fpage>97</fpage>
<lpage>109</lpage>
<pub-id pub-id-type="doi">10.1007/s00439-014-1498-1</pub-id>
<pub-id pub-id-type="pmid">25326669</pub-id>
</element-citation>
</ref>
<ref id="CR63">
<label>63.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iossifov</surname>
<given-names>I</given-names>
</name>
<name>
<surname>O’Roak</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Sanders</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Ronemus</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Krumm</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Levy</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Stessman</surname>
<given-names>HA</given-names>
</name>
<name>
<surname>Witherspoon</surname>
<given-names>KT</given-names>
</name>
<name>
<surname>Vives</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Patterson</surname>
<given-names>KE</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The contribution of de novo coding mutations to autism spectrum disorder</article-title>
<source/>Nature
          <year>2014</year>
<volume>515</volume>
<issue>7526</issue>
<fpage>216</fpage>
<lpage>21</lpage>
<pub-id pub-id-type="doi">10.1038/nature13908</pub-id>
<pub-id pub-id-type="pmid">25363768</pub-id>
</element-citation>
</ref>
<ref id="CR64">
<label>64.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Rubeis</surname>
<given-names>S</given-names>
</name>
<name>
<surname>He</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Goldberg</surname>
<given-names>AP</given-names>
</name>
<name>
<surname>Poultney</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>Samocha</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Cicek</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Kou</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Fromer</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Walker</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Synaptic, transcriptional and chromatin genes disrupted in autism</article-title>
<source/>Nature
          <year>2014</year>
<volume>515</volume>
<issue>7526</issue>
<fpage>209</fpage>
<lpage>15</lpage>
<pub-id pub-id-type="doi">10.1038/nature13772</pub-id>
<pub-id pub-id-type="pmid">25363760</pub-id>
</element-citation>
</ref>
<ref id="CR65">
<label>65.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Snijders Blok</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Madsen</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Juusola</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Gilissen</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Baralle</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Reijnders</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Venselaar</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Helsmoortel</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Cho</surname>
<given-names>MT</given-names>
</name>
<name>
<surname>Hoischen</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mutations in DDX3X are a common cause of unexplained intellectual disability with gender-specific effects on Wnt signaling</article-title>
<source/>Am J Hum Genet
          <year>2015</year>
<volume>97</volume>
<issue>2</issue>
<fpage>343</fpage>
<lpage>52</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2015.07.004</pub-id>
<pub-id pub-id-type="pmid">26235985</pub-id>
</element-citation>
</ref>
<ref id="CR66">
<label>66.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cruciat</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Dolde</surname>
<given-names>C</given-names>
</name>
<name>
<surname>de Groot</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Ohkawara</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Reinhard</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Korswagen</surname>
<given-names>HC</given-names>
</name>
<name>
<surname>Niehrs</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>RNA helicase DDX3 is a regulatory subunit of casein kinase 1 in Wnt-β-catenin signaling</article-title>
<source/>Science
          <year>2013</year>
<volume>339</volume>
<issue>6126</issue>
<fpage>1436</fpage>
<lpage>41</lpage>
<pub-id pub-id-type="doi">10.1126/science.1231499</pub-id>
<pub-id pub-id-type="pmid">23413191</pub-id>
</element-citation>
</ref>
<ref id="CR67">
<label>67.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lijam</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Paylor</surname>
<given-names>R</given-names>
</name>
<name>
<surname>McDonald</surname>
<given-names>MP</given-names>
</name>
<name>
<surname>Crawley</surname>
<given-names>JN</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>CX</given-names>
</name>
<name>
<surname>Herrup</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Stevens</surname>
<given-names>KE</given-names>
</name>
<name>
<surname>Maccaferri</surname>
<given-names>G</given-names>
</name>
<name>
<surname>McBain</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Sussman</surname>
<given-names>DJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Social interaction and sensorimotor gating abnormalities in mice lacking Dvl1</article-title>
<source/>Cell
          <year>1997</year>
<volume>90</volume>
<issue>5</issue>
<fpage>895</fpage>
<lpage>905</lpage>
<pub-id pub-id-type="doi">10.1016/S0092-8674(00)80354-2</pub-id>
<pub-id pub-id-type="pmid">9298901</pub-id>
</element-citation>
</ref>
<ref id="CR68">
<label>68.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Long</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>LaPorte</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Paylor</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Wynshaw-Boris</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Expanded characterization of the social interaction abnormalities in mice lacking Dvl1</article-title>
<source/>Genes Brain Behav
          <year>2004</year>
<volume>3</volume>
<issue>1</issue>
<fpage>51</fpage>
<lpage>62</lpage>
<pub-id pub-id-type="doi">10.1046/j.1601-183x.2003.00045.x</pub-id>
<pub-id pub-id-type="pmid">14960015</pub-id>
</element-citation>
</ref>
<ref id="CR69">
<label>69.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Belinson</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Nakatani</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Babineau</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Birnbaum</surname>
<given-names>RY</given-names>
</name>
<name>
<surname>Ellegood</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Bershteyn</surname>
<given-names>M</given-names>
</name>
<name>
<surname>McEvilly</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Long</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Willert</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Klein</surname>
<given-names>OD</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Prenatal beta-catenin/Brn2/Tbr2 transcriptional cascade regulates adult social and stereotypic behaviors</article-title>
<source/>Mol Psychiatry
          <year>2016</year>
<volume>21</volume>
<fpage>1417</fpage>
<lpage>33</lpage>
<pub-id pub-id-type="doi">10.1038/mp.2015.207</pub-id>
<pub-id pub-id-type="pmid">26830142</pub-id>
</element-citation>
</ref>
<ref id="CR70">
<label>70.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meijer</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Flajolet</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Greengard</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Pharmacological inhibitors of glycogen synthase kinase 3</article-title>
<source/>Trends Pharmacol Sci
          <year>2004</year>
<volume>25</volume>
<issue>9</issue>
<fpage>471</fpage>
<lpage>80</lpage>
<pub-id pub-id-type="doi">10.1016/j.tips.2004.07.006</pub-id>
<pub-id pub-id-type="pmid">15559249</pub-id>
</element-citation>
</ref>
<ref id="CR71">
<label>71.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>O’Brien</surname>
<given-names>WT</given-names>
</name>
<name>
<surname>Harper</surname>
<given-names>AD</given-names>
</name>
<name>
<surname>Jove</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Woodgett</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Maretto</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Piccolo</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Klein</surname>
<given-names>PS</given-names>
</name>
</person-group>
<article-title>Glycogen synthase kinase-3β haploinsufficiency mimics the behavioral and molecular effects of lithium</article-title>
<source/>J Neurosci
          <year>2004</year>
<volume>24</volume>
<issue>30</issue>
<fpage>6791</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.4753-03.2004</pub-id>
<pub-id pub-id-type="pmid">15282284</pub-id>
</element-citation>
</ref>
<ref id="CR72">
<label>72.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Latapy</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Rioux</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Guitton</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Beaulieu</surname>
<given-names>JM</given-names>
</name>
</person-group>
<article-title>Selective deletion of forebrain glycogen synthase kinase 3β reveals a central role in serotonin-sensitive anxiety and social behaviour</article-title>
<source/>Philos Trans R Soc Lond B Biol Sci
          <year>2012</year>
<volume>367</volume>
<issue>1601</issue>
<fpage>2460</fpage>
<lpage>74</lpage>
<pub-id pub-id-type="doi">10.1098/rstb.2012.0094</pub-id>
<pub-id pub-id-type="pmid">22826345</pub-id>
</element-citation>
</ref>
<ref id="CR73">
<label>73.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bhakar</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Dolen</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Bear</surname>
<given-names>MF</given-names>
</name>
</person-group>
<article-title>The pathophysiology of fragile X (and what it teaches us about synapses)</article-title>
<source/>Annu Rev Neurosci
          <year>2012</year>
<volume>35</volume>
<fpage>417</fpage>
<lpage>43</lpage>
<pub-id pub-id-type="doi">10.1146/annurev-neuro-060909-153138</pub-id>
<pub-id pub-id-type="pmid">22483044</pub-id>
</element-citation>
</ref>
<ref id="CR74">
<label>74.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bear</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Huber</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Warren</surname>
<given-names>ST</given-names>
</name>
</person-group>
<article-title>The mGluR theory of fragile X mental retardation</article-title>
<source/>Trends Neurosci
          <year>2004</year>
<volume>27</volume>
<issue>7</issue>
<fpage>370</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="doi">10.1016/j.tins.2004.04.009</pub-id>
<pub-id pub-id-type="pmid">15219735</pub-id>
</element-citation>
</ref>
<ref id="CR75">
<label>75.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Comery</surname>
<given-names>TA</given-names>
</name>
<name>
<surname>Harris</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Willems</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Oostra</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Irwin</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Weiler</surname>
<given-names>IJ</given-names>
</name>
<name>
<surname>Greenough</surname>
<given-names>WT</given-names>
</name>
</person-group>
<article-title>Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>1997</year>
<volume>94</volume>
<issue>10</issue>
<fpage>5401</fpage>
<lpage>4</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.94.10.5401</pub-id>
<pub-id pub-id-type="pmid">9144249</pub-id>
</element-citation>
</ref>
<ref id="CR76">
<label>76.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mines</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Yuskaitis</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>King</surname>
<given-names>MK</given-names>
</name>
<name>
<surname>Beurel</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Jope</surname>
<given-names>RS</given-names>
</name>
</person-group>
<article-title>GSK3 influences social preference and anxiety-related behaviors during social interaction in a mouse model of fragile X syndrome and autism</article-title>
<source/>PLoS One
          <year>2010</year>
<volume>5</volume>
<issue>3</issue>
<fpage>e9706</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0009706</pub-id>
<pub-id pub-id-type="pmid">20300527</pub-id>
</element-citation>
</ref>
<ref id="CR77">
<label>77.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Franklin</surname>
<given-names>AV</given-names>
</name>
<name>
<surname>King</surname>
<given-names>MK</given-names>
</name>
<name>
<surname>Palomo</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Martinez</surname>
<given-names>A</given-names>
</name>
<name>
<surname>McMahon</surname>
<given-names>LL</given-names>
</name>
<name>
<surname>Jope</surname>
<given-names>RS</given-names>
</name>
</person-group>
<article-title>Glycogen synthase kinase-3 inhibitors reverse deficits in long-term potentiation and cognition in fragile X mice</article-title>
<source/>Biol Psychiatry
          <year>2014</year>
<volume>75</volume>
<issue>3</issue>
<fpage>198</fpage>
<lpage>206</lpage>
<pub-id pub-id-type="doi">10.1016/j.biopsych.2013.08.003</pub-id>
<pub-id pub-id-type="pmid">24041505</pub-id>
</element-citation>
</ref>
<ref id="CR78">
<label>78.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mines</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Jope</surname>
<given-names>RS</given-names>
</name>
</person-group>
<article-title>Glycogen synthase kinase-3: a promising therapeutic target for fragile x syndrome</article-title>
<source/>Front Mol Neurosci
          <year>2011</year>
<volume>4</volume>
<fpage>35</fpage>
<pub-id pub-id-type="doi">10.3389/fnmol.2011.00035</pub-id>
<pub-id pub-id-type="pmid">22053151</pub-id>
</element-citation>
</ref>
<ref id="CR79">
<label>79.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yuskaitis</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Mines</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>King</surname>
<given-names>MK</given-names>
</name>
<name>
<surname>Sweatt</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Jope</surname>
<given-names>RS</given-names>
</name>
</person-group>
<article-title>Lithium ameliorates altered glycogen synthase kinase-3 and behavior in a mouse model of fragile X syndrome</article-title>
<source/>Biochem Pharmacol
          <year>2010</year>
<volume>79</volume>
<issue>4</issue>
<fpage>632</fpage>
<lpage>46</lpage>
<pub-id pub-id-type="doi">10.1016/j.bcp.2009.09.023</pub-id>
<pub-id pub-id-type="pmid">19799873</pub-id>
</element-citation>
</ref>
<ref id="CR80">
<label>80.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Min</surname>
<given-names>WW</given-names>
</name>
<name>
<surname>Yuskaitis</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Sikorski</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Jope</surname>
<given-names>RS</given-names>
</name>
<name>
<surname>Bauchwitz</surname>
<given-names>RP</given-names>
</name>
</person-group>
<article-title>Elevated glycogen synthase kinase-3 activity in Fragile X mice: key metabolic regulator with evidence for treatment potential</article-title>
<source/>Neuropharmacology
          <year>2009</year>
<volume>56</volume>
<issue>2</issue>
<fpage>463</fpage>
<lpage>72</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuropharm.2008.09.017</pub-id>
<pub-id pub-id-type="pmid">18952114</pub-id>
</element-citation>
</ref>
<ref id="CR81">
<label>81.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Lithium ameliorates open-field and elevated plus maze behaviors, and brain phospho-glycogen synthase kinase 3-beta expression in fragile X syndrome model mice</article-title>
<source/>Neurosciences
          <year>2013</year>
<volume>18</volume>
<issue>4</issue>
<fpage>356</fpage>
<lpage>62</lpage>
<pub-id pub-id-type="pmid">24141459</pub-id>
</element-citation>
</ref>
<ref id="CR82">
<label>82.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guo</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Murthy</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>EB</given-names>
</name>
<name>
<surname>Schaller</surname>
<given-names>EG</given-names>
</name>
<name>
<surname>Allan</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>X</given-names>
</name>
</person-group>
<article-title>Inhibition of GSK3β improves hippocampus-dependent learning and rescues neurogenesis in a mouse model of fragile X syndrome</article-title>
<source/>Hum Mol Genet
          <year>2012</year>
<volume>21</volume>
<issue>3</issue>
<fpage>681</fpage>
<lpage>91</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/ddr501</pub-id>
<pub-id pub-id-type="pmid">22048960</pub-id>
</element-citation>
</ref>
<ref id="CR83">
<label>83.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Matic</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Eninger</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Bardoni</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Davidovic</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Macek</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Quantitative phosphoproteomics of murine Fmr1-KO cell lines provides new insights into FMRP-dependent signal transduction mechanisms</article-title>
<source/>J Proteome Res
          <year>2014</year>
<volume>13</volume>
<issue>10</issue>
<fpage>4388</fpage>
<lpage>97</lpage>
<pub-id pub-id-type="doi">10.1021/pr5006372</pub-id>
<pub-id pub-id-type="pmid">25168779</pub-id>
</element-citation>
</ref>
<ref id="CR84">
<label>84.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luo</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Shan</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Smrt</surname>
<given-names>RD</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>EB</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Pfeiffer</surname>
<given-names>RL</given-names>
</name>
<name>
<surname>Szulwach</surname>
<given-names>KE</given-names>
</name>
<name>
<surname>Duan</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Barkho</surname>
<given-names>BZ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Fragile x mental retardation protein regulates proliferation and differentiation of adult neural stem/progenitor cells</article-title>
<source/>PLoS Genet
          <year>2010</year>
<volume>6</volume>
<issue>4</issue>
<pub-id pub-id-type="doi">10.1371/journal.pgen.1000898</pub-id>
<pub-id pub-id-type="pmid">20386739</pub-id>
</element-citation>
</ref>
<ref id="CR85">
<label>85.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Ge</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Frank</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Madison</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Koehler</surname>
<given-names>AN</given-names>
</name>
<name>
<surname>Doud</surname>
<given-names>MK</given-names>
</name>
<name>
<surname>Tassa</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Berry</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Soda</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>KK</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Disrupted in schizophrenia 1 regulates neuronal progenitor proliferation via modulation of GSK3beta/beta-catenin signaling</article-title>
<source/>Cell
          <year>2009</year>
<volume>136</volume>
<issue>6</issue>
<fpage>1017</fpage>
<lpage>31</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2008.12.044</pub-id>
<pub-id pub-id-type="pmid">19303846</pub-id>
</element-citation>
</ref>
<ref id="CR86">
<label>86.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Singh</surname>
<given-names>KK</given-names>
</name>
<name>
<surname>Ge</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Mao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Drane</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Meletis</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Samuels</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Tsai</surname>
<given-names>LH</given-names>
</name>
</person-group>
<article-title>Dixdc1 is a critical regulator of DISC1 and embryonic cortical development</article-title>
<source/>Neuron
          <year>2010</year>
<volume>67</volume>
<issue>1</issue>
<fpage>33</fpage>
<lpage>48</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2010.06.002</pub-id>
<pub-id pub-id-type="pmid">20624590</pub-id>
</element-citation>
</ref>
<ref id="CR87">
<label>87.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boccitto</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Doshi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Newton</surname>
<given-names>IP</given-names>
</name>
<name>
<surname>Nathke</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Neve</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Mao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhai</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Kalb</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Opposing actions of the synapse-associated protein of 97-kDa molecular weight (SAP97) and Disrupted in Schizophrenia 1 (DISC1) on Wnt/β-catenin signaling</article-title>
<source/>Neuroscience
          <year>2016</year>
<volume>326</volume>
<fpage>22</fpage>
<lpage>30</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroscience.2016.03.048</pub-id>
<pub-id pub-id-type="pmid">27026592</pub-id>
</element-citation>
</ref>
<ref id="CR88">
<label>88.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Srikanth</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Callahan</surname>
<given-names>DG</given-names>
</name>
<name>
<surname>Makovkina</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Muratore</surname>
<given-names>CR</given-names>
</name>
<name>
<surname>Lalli</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Boyd</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Kosik</surname>
<given-names>KS</given-names>
</name>
<name>
<surname>Selkoe</surname>
<given-names>DJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Genomic DISC1disruption in hiPSCs alters Wnt signaling and neural cell fate</article-title>
<source/>Cell Rep
          <year>2015</year>
<volume>12</volume>
<issue>9</issue>
<fpage>1414</fpage>
<lpage>29</lpage>
<pub-id pub-id-type="doi">10.1016/j.celrep.2015.07.061</pub-id>
<pub-id pub-id-type="pmid">26299970</pub-id>
</element-citation>
</ref>
<ref id="CR89">
<label>89.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Singh</surname>
<given-names>KK</given-names>
</name>
<name>
<surname>De Rienzo</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Drane</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Mao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Flood</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Madison</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ferreira</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bergen</surname>
<given-names>S</given-names>
</name>
<name>
<surname>King</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Sklar</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Common DISC1 polymorphisms disrupt Wnt/GSK3beta signaling and brain development</article-title>
<source/>Neuron
          <year>2011</year>
<volume>72</volume>
<issue>4</issue>
<fpage>545</fpage>
<lpage>58</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2011.09.030</pub-id>
<pub-id pub-id-type="pmid">22099458</pub-id>
</element-citation>
</ref>
<ref id="CR90">
<label>90.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seshadri</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Faust</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Ishizuka</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Delevich</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Chung</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Cowles</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Niwa</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Jaaro-Peled</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Tomoda</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Interneuronal DISC1 regulates NRG1-ErbB4 signalling and excitatory-inhibitory synapse formation in the mature cortex</article-title>
<source/>Nat Commun
          <year>2015</year>
<volume>6</volume>
<fpage>10118</fpage>
<pub-id pub-id-type="doi">10.1038/ncomms10118</pub-id>
<pub-id pub-id-type="pmid">26656849</pub-id>
</element-citation>
</ref>
<ref id="CR91">
<label>91.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Clapcote</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Lipina</surname>
<given-names>TV</given-names>
</name>
<name>
<surname>Millar</surname>
<given-names>JK</given-names>
</name>
<name>
<surname>Mackie</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Christie</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ogawa</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Lerch</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Trimble</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Uchiyama</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sakuraba</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Behavioral phenotypes of Disc1 missense mutations in mice</article-title>
<source/>Neuron
          <year>2007</year>
<volume>54</volume>
<issue>3</issue>
<fpage>387</fpage>
<lpage>402</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2007.04.015</pub-id>
<pub-id pub-id-type="pmid">17481393</pub-id>
</element-citation>
</ref>
<ref id="CR92">
<label>92.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abazyan</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Nomura</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kannan</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Ishizuka</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Tamashiro</surname>
<given-names>KL</given-names>
</name>
<name>
<surname>Nucifora</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Pogorelov</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Ladenheim</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Krasnova</surname>
<given-names>IN</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Prenatal interaction of mutant DISC1 and immune activation produces adult psychopathology</article-title>
<source/>Biol Psychiatry
          <year>2010</year>
<volume>68</volume>
<issue>12</issue>
<fpage>1172</fpage>
<lpage>81</lpage>
<pub-id pub-id-type="doi">10.1016/j.biopsych.2010.09.022</pub-id>
<pub-id pub-id-type="pmid">21130225</pub-id>
</element-citation>
</ref>
<ref id="CR93">
<label>93.</label>
<mixed-citation publication-type="other">Furukubo-Tokunaga K, Kurita K, Honjo K, Pandey H, Ando T, Takayama K, Arai Y, Mochizuki H, Ando M, Kamiya A, et al. DISC1 causes associative memory and neurodevelopmental defects in fruit flies. Mol Psychiatry. 2016.</mixed-citation>
</ref>
<ref id="CR94">
<label>94.</label>
<mixed-citation publication-type="other">Saito A, Taniguchi Y, Rannals MD, Merfeld EB, Ballinger MD, Koga M, Ohtani Y, Gurley DA, Sedlak TW, Cross A, et al. Early postnatal GABA receptor modulation reverses deficits in neuronal maturation in a conditional neurodevelopmental mouse model of DISC1. Mol Psychiatry. 2016.</mixed-citation>
</ref>
<ref id="CR95">
<label>95.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Durak</surname>
<given-names>O</given-names>
</name>
<name>
<surname>de Anda</surname>
<given-names>FC</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>KK</given-names>
</name>
<name>
<surname>Leussis</surname>
<given-names>MP</given-names>
</name>
<name>
<surname>Petryshen</surname>
<given-names>TL</given-names>
</name>
<name>
<surname>Sklar</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Tsai</surname>
<given-names>LH</given-names>
</name>
</person-group>
<article-title>Ankyrin-G regulates neurogenesis and Wnt signaling by altering the subcellular localization of β-catenin</article-title>
<source/>Mol Psychiatry
          <year>2015</year>
<volume>20</volume>
<issue>3</issue>
<fpage>388</fpage>
<lpage>97</lpage>
<pub-id pub-id-type="doi">10.1038/mp.2014.42</pub-id>
<pub-id pub-id-type="pmid">24821222</pub-id>
</element-citation>
</ref>
<ref id="CR96">
<label>96.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iqbal</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Vandeweyer</surname>
<given-names>G</given-names>
</name>
<name>
<surname>van der Voet</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Waryah</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Zahoor</surname>
<given-names>MY</given-names>
</name>
<name>
<surname>Besseling</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Roca</surname>
<given-names>LT</given-names>
</name>
<name>
<surname>Vulto-van Silfhout</surname>
<given-names>AT</given-names>
</name>
<name>
<surname>Nijhof</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Kramer</surname>
<given-names>JM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Homozygous and heterozygous disruptions of ANK3: at the crossroads of neurodevelopmental and psychiatric disorders</article-title>
<source/>Hum Mol Genet
          <year>2013</year>
<volume>22</volume>
<issue>10</issue>
<fpage>1960</fpage>
<lpage>70</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/ddt043</pub-id>
<pub-id pub-id-type="pmid">23390136</pub-id>
</element-citation>
</ref>
<ref id="CR97">
<label>97.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smith</surname>
<given-names>KR</given-names>
</name>
<name>
<surname>Kopeikina</surname>
<given-names>KJ</given-names>
</name>
<name>
<surname>Fawcett-Patel</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Leaderbrand</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Schurmann</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Myczek</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Radulovic</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Swanson</surname>
<given-names>GT</given-names>
</name>
<name>
<surname>Penzes</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Psychiatric risk factor ANK3/ankyrin-G nanodomains regulate the structure and function of glutamatergic synapses</article-title>
<source/>Neuron
          <year>2014</year>
<volume>84</volume>
<issue>2</issue>
<fpage>399</fpage>
<lpage>415</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2014.10.010</pub-id>
<pub-id pub-id-type="pmid">25374361</pub-id>
</element-citation>
</ref>
<ref id="CR98">
<label>98.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leussis</surname>
<given-names>MP</given-names>
</name>
<name>
<surname>Berry-Scott</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Saito</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Jhuang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>de Haan</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Alkan</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Luce</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Madison</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Sklar</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Serre</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The ANK3 bipolar disorder gene regulates psychiatric-related behaviors that are modulated by lithium and stress</article-title>
<source/>Biol Psychiatry
          <year>2013</year>
<volume>73</volume>
<issue>7</issue>
<fpage>683</fpage>
<lpage>90</lpage>
<pub-id pub-id-type="doi">10.1016/j.biopsych.2012.10.016</pub-id>
<pub-id pub-id-type="pmid">23237312</pub-id>
</element-citation>
</ref>
<ref id="CR99">
<label>99.</label>
<mixed-citation publication-type="other">Singh KK. Dixdc1 is a critical regulator of DISC1 and embryonic cortical development supplemental information. Neuron. 2010.</mixed-citation>
</ref>
<ref id="CR100">
<label>100.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kivimae</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>PM</given-names>
</name>
<name>
<surname>Kapfhamer</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Ruan</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Heberlein</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Rubenstein</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Cheyette</surname>
<given-names>BN</given-names>
</name>
</person-group>
<article-title>Abnormal behavior in mice mutant for the Disc1 binding partner, Dixdc1</article-title>
<source/>Transl Psychiatry
          <year>2011</year>
<volume>1</volume>
<pub-id pub-id-type="doi">10.1038/tp.2011.41</pub-id>
<pub-id pub-id-type="pmid">22832659</pub-id>
</element-citation>
</ref>
<ref id="CR101">
<label>101.</label>
<mixed-citation publication-type="other">Martin PM, Stanley RE, Ross AP, Freitas AE, Moyer CE, Brumback AC, Iafrati J, Stapornwongkul KS, Dominguez S, Kivimae S, et al. DIXDC1 contributes to psychiatric susceptibility by regulating dendritic spine and glutamatergic synapse density via GSK3 and Wnt/beta-catenin signaling. Mol Psychiatry. 2016. Epub ahead of print.</mixed-citation>
</ref>
<ref id="CR102">
<label>102.</label>
<mixed-citation publication-type="other">Kwan V, Meka DP, White SH, Hung CL, Holzapfel NT, Walker S, Murtaza N, Unda BK, Schwanke B, Yuen RK, Habing K, Milsom C, Hope KJ, Truant R, Scherer SW, Calderon de Anda F, Singh KK. DIXDC1 Phosphorylation and Control of Dendritic Morphology Are Impaired by Rare Genetic Variants. Cell Rep. 2016 Nov 8;17(7):1892-1904. doi: 10.1016/j.celrep.2016.10.047.</mixed-citation>
</ref>
<ref id="CR103">
<label>103.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>XL</given-names>
</name>
<name>
<surname>Giacobini</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Anderlid</surname>
<given-names>BM</given-names>
</name>
<name>
<surname>Anckarsater</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Omrani</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Gillberg</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Nordenskjold</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lindblom</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Association of adenomatous polyposis coli (APC) gene polymorphisms with autism spectrum disorder (ASD)</article-title>
<source/>Am J Med Genet B Neuropsychiatr Genet
          <year>2007</year>
<volume>144B</volume>
<issue>3</issue>
<fpage>351</fpage>
<lpage>4</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.b.30415</pub-id>
<pub-id pub-id-type="pmid">17221838</pub-id>
</element-citation>
</ref>
<ref id="CR104">
<label>104.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sowers</surname>
<given-names>LP</given-names>
</name>
<name>
<surname>Loo</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Campbell</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Ulrich</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Paemka</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Wassink</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Meyer</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Bing</surname>
<given-names>X</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Disruption of the non-canonical Wnt gene PRICKLE2 leads to autism-like behaviors with evidence for hippocampal synaptic dysfunction</article-title>
<source/>Mol Psychiatry
          <year>2013</year>
<volume>18</volume>
<issue>10</issue>
<fpage>1077</fpage>
<lpage>89</lpage>
<pub-id pub-id-type="doi">10.1038/mp.2013.71</pub-id>
<pub-id pub-id-type="pmid">23711981</pub-id>
</element-citation>
</ref>
<ref id="CR105">
<label>105.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sowers</surname>
<given-names>LP</given-names>
</name>
<name>
<surname>Mouw</surname>
<given-names>TJ</given-names>
</name>
<name>
<surname>Ferguson</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Wemmie</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Mohapatra</surname>
<given-names>DP</given-names>
</name>
<name>
<surname>Bassuk</surname>
<given-names>AG</given-names>
</name>
</person-group>
<article-title>The non-canonical Wnt ligand Wnt5a rescues morphological deficits in Prickle2-deficient hippocampal neurons</article-title>
<source/>Mol Psychiatry
          <year>2013</year>
<volume>18</volume>
<issue>10</issue>
<fpage>1049</fpage>
<pub-id pub-id-type="doi">10.1038/mp.2013.119</pub-id>
<pub-id pub-id-type="pmid">24056908</pub-id>
</element-citation>
</ref>
<ref id="CR106">
<label>106.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nagaoka</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Tabuchi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kishi</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>PDZ interaction of Vangl2 links PSD-95 and Prickle2 but plays only a limited role in the synaptic localisation of Vangl2</article-title>
<source/>Scientific reports
          <year>2015</year>
<volume>5</volume>
<fpage>12916</fpage>
<pub-id pub-id-type="doi">10.1038/srep12916</pub-id>
<pub-id pub-id-type="pmid">26257100</pub-id>
</element-citation>
</ref>
<ref id="CR107">
<label>107.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martin</surname>
<given-names>PM</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Robin</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Lam</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Rabinowitz</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Erdman</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Quinn</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Weiss</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Hamilton</surname>
<given-names>SP</given-names>
</name>
<name>
<surname>Kwok</surname>
<given-names>PY</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A rare WNT1 missense variant overrepresented in ASD leads to increased Wnt signal pathway activation</article-title>
<source/>Transl Psychiatry
          <year>2013</year>
<volume>3</volume>
<pub-id pub-id-type="doi">10.1038/tp.2013.75</pub-id>
<pub-id pub-id-type="pmid">24002087</pub-id>
</element-citation>
</ref>
<ref id="CR108">
<label>108.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Christensen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Gronborg</surname>
<given-names>TK</given-names>
</name>
<name>
<surname>Sorensen</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Schendel</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Parner</surname>
<given-names>ET</given-names>
</name>
<name>
<surname>Pedersen</surname>
<given-names>LH</given-names>
</name>
<name>
<surname>Vestergaard</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism</article-title>
<source/>Jama
          <year>2013</year>
<volume>309</volume>
<issue>16</issue>
<fpage>1696</fpage>
<lpage>703</lpage>
<pub-id pub-id-type="doi">10.1001/jama.2013.2270</pub-id>
<pub-id pub-id-type="pmid">23613074</pub-id>
</element-citation>
</ref>
<ref id="CR109">
<label>109.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hall</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Brennan</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Goold</surname>
<given-names>RG</given-names>
</name>
<name>
<surname>Cleverley</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Lucas</surname>
<given-names>FR</given-names>
</name>
<name>
<surname>Gordon-Weeks</surname>
<given-names>PR</given-names>
</name>
<name>
<surname>Salinas</surname>
<given-names>PC</given-names>
</name>
</person-group>
<article-title>Valproate regulates GSK-3-mediated axonal remodeling and synapsin I clustering in developing neurons</article-title>
<source/>Mol Cell Neurosci
          <year>2002</year>
<volume>20</volume>
<issue>2</issue>
<fpage>257</fpage>
<lpage>70</lpage>
<pub-id pub-id-type="doi">10.1006/mcne.2002.1117</pub-id>
<pub-id pub-id-type="pmid">12093158</pub-id>
</element-citation>
</ref>
<ref id="CR110">
<label>110.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Long</surname>
<given-names>ZY</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>YM</given-names>
</name>
</person-group>
<article-title>Wnt signaling pathway participates in valproic acid-induced neuronal differentiation of neural stem cells</article-title>
<source/>Int J Clin Exp Pathol
          <year>2015</year>
<volume>8</volume>
<issue>1</issue>
<fpage>578</fpage>
<lpage>85</lpage>
<pub-id pub-id-type="pmid">25755748</pub-id>
</element-citation>
</ref>
<ref id="CR111">
<label>111.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wiltse</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Mode of action: inhibition of histone deacetylase, altering WNT-dependent gene expression, and regulation of beta-catenin—developmental effects of valproic acid</article-title>
<source/>Crit Rev Toxicol
          <year>2005</year>
<volume>35</volume>
<issue>8–9</issue>
<fpage>727</fpage>
<lpage>38</lpage>
<pub-id pub-id-type="doi">10.1080/10408440591007403</pub-id>
<pub-id pub-id-type="pmid">16417040</pub-id>
</element-citation>
</ref>
<ref id="CR112">
<label>112.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Downregulating the canonical Wnt/β-catenin signaling pathway attenuates the susceptibility to autism-like phenotypes by decreasing oxidative stress</article-title>
<source/>Neurochem Res
          <year>2012</year>
<volume>37</volume>
<issue>7</issue>
<fpage>1409</fpage>
<lpage>19</lpage>
<pub-id pub-id-type="doi">10.1007/s11064-012-0724-2</pub-id>
<pub-id pub-id-type="pmid">22374471</pub-id>
</element-citation>
</ref>
<ref id="CR113">
<label>113.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Go</surname>
<given-names>HS</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>KC</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>Jeon</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Kwon</surname>
<given-names>KJ</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Cheong</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Ryu</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>CH</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Prenatal exposure to valproic acid increases the neural progenitor cell pool and induces macrocephaly in rat brain via a mechanism involving the GSK-3β/β-catenin pathway</article-title>
<source/>Neuropharmacology
          <year>2012</year>
<volume>63</volume>
<issue>6</issue>
<fpage>1028</fpage>
<lpage>41</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuropharm.2012.07.028</pub-id>
<pub-id pub-id-type="pmid">22841957</pub-id>
</element-citation>
</ref>
<ref id="CR114">
<label>114.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Phiel</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>EY</given-names>
</name>
<name>
<surname>Guenther</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Lazar</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Klein</surname>
<given-names>PS</given-names>
</name>
</person-group>
<article-title>Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen</article-title>
<source/>J Biol Chem
          <year>2001</year>
<volume>276</volume>
<issue>39</issue>
<fpage>36734</fpage>
<lpage>41</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M101287200</pub-id>
<pub-id pub-id-type="pmid">11473107</pub-id>
</element-citation>
</ref>
<ref id="CR115">
<label>115.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fang</surname>
<given-names>WQ</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>WW</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Yung</surname>
<given-names>WH</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Ip</surname>
<given-names>NY</given-names>
</name>
</person-group>
<article-title>Overproduction of upper-layer neurons in the neocortex leads to autism-like features in mice</article-title>
<source/>Cell Rep
          <year>2014</year>
<volume>9</volume>
<issue>5</issue>
<fpage>1635</fpage>
<lpage>43</lpage>
<pub-id pub-id-type="doi">10.1016/j.celrep.2014.11.003</pub-id>
<pub-id pub-id-type="pmid">25466248</pub-id>
</element-citation>
</ref>
<ref id="CR116">
<label>116.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Emamian</surname>
<given-names>ES</given-names>
</name>
<name>
<surname>Hall</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Birnbaum</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Karayiorgou</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gogos</surname>
<given-names>JA</given-names>
</name>
</person-group>
<article-title>Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia</article-title>
<source/>Nat Genet
          <year>2004</year>
<volume>36</volume>
<issue>2</issue>
<fpage>131</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="doi">10.1038/ng1296</pub-id>
<pub-id pub-id-type="pmid">14745448</pub-id>
</element-citation>
</ref>
<ref id="CR117">
<label>117.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sutton</surname>
<given-names>LP</given-names>
</name>
<name>
<surname>Honardoust</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Mouyal</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Rajakumar</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Rushlow</surname>
<given-names>WJ</given-names>
</name>
</person-group>
<article-title>Activation of the canonical Wnt pathway by the antipsychotics haloperidol and clozapine involves dishevelled-3</article-title>
<source/>J Neurochem
          <year>2007</year>
<volume>102</volume>
<issue>1</issue>
<fpage>153</fpage>
<lpage>69</lpage>
<pub-id pub-id-type="doi">10.1111/j.1471-4159.2007.04527.x</pub-id>
<pub-id pub-id-type="pmid">17472703</pub-id>
</element-citation>
</ref>
<ref id="CR118">
<label>118.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sutton</surname>
<given-names>LP</given-names>
</name>
<name>
<surname>Rushlow</surname>
<given-names>WJ</given-names>
</name>
</person-group>
<article-title>The effects of neuropsychiatric drugs on glycogen synthase kinase-3 signaling</article-title>
<source/>Neuroscience
          <year>2011</year>
<volume>199</volume>
<fpage>116</fpage>
<lpage>24</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroscience.2011.09.056</pub-id>
<pub-id pub-id-type="pmid">22001305</pub-id>
</element-citation>
</ref>
<ref id="CR119">
<label>119.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Launay</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Mouillet-Richard</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Baudry</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Pietri</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kellermann</surname>
<given-names>O</given-names>
</name>
</person-group>
<article-title>Raphe-mediated signals control the hippocampal response to SRI antidepressants via miR-16</article-title>
<source/>Transl Psychiatry
          <year>2011</year>
<volume>1</volume>
<fpage>e56</fpage>
<pub-id pub-id-type="doi">10.1038/tp.2011.54</pub-id>
<pub-id pub-id-type="pmid">22833211</pub-id>
</element-citation>
</ref>
<ref id="CR120">
<label>120.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baudry</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Mouillet-Richard</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Schneider</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Launay</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Kellermann</surname>
<given-names>O</given-names>
</name>
</person-group>
<article-title>miR-16 targets the serotonin transporter: a new facet for adaptive responses to antidepressants</article-title>
<source/>Science
          <year>2010</year>
<volume>329</volume>
<issue>5998</issue>
<fpage>1537</fpage>
<lpage>41</lpage>
<pub-id pub-id-type="doi">10.1126/science.1193692</pub-id>
<pub-id pub-id-type="pmid">20847275</pub-id>
</element-citation>
</ref>
<ref id="CR121">
<label>121.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Klein</surname>
<given-names>PS</given-names>
</name>
<name>
<surname>Melton</surname>
<given-names>DA</given-names>
</name>
</person-group>
<article-title>A molecular mechanism for the effect of lithium on development</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>1996</year>
<volume>93</volume>
<issue>16</issue>
<fpage>8455</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.93.16.8455</pub-id>
<pub-id pub-id-type="pmid">8710892</pub-id>
</element-citation>
</ref>
<ref id="CR122">
<label>122.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hedgepeth</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Conrad</surname>
<given-names>LJ</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>HC</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>VM</given-names>
</name>
<name>
<surname>Klein</surname>
<given-names>PS</given-names>
</name>
</person-group>
<article-title>Activation of the Wnt signaling pathway: a molecular mechanism for lithium action</article-title>
<source/>Dev Biol
          <year>1997</year>
<volume>185</volume>
<issue>1</issue>
<fpage>82</fpage>
<lpage>91</lpage>
<pub-id pub-id-type="doi">10.1006/dbio.1997.8552</pub-id>
<pub-id pub-id-type="pmid">9169052</pub-id>
</element-citation>
</ref>
<ref id="CR123">
<label>123.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Phiel</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Spece</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Gurvich</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Klein</surname>
<given-names>PS</given-names>
</name>
</person-group>
<article-title>Inhibitory phosphorylation of glycogen synthase kinase-3 (GSK-3) in response to lithium. Evidence for autoregulation of GSK-3</article-title>
<source/>J Biol Chem
          <year>2003</year>
<volume>278</volume>
<issue>35</issue>
<fpage>33067</fpage>
<lpage>77</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M212635200</pub-id>
<pub-id pub-id-type="pmid">12796505</pub-id>
</element-citation>
</ref>
<ref id="CR124">
<label>124.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mines</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Jope</surname>
<given-names>RS</given-names>
</name>
</person-group>
<article-title>Brain region differences in regulation of Akt and GSK3 by chronic stimulant administration in mice</article-title>
<source/>Cell Signal
          <year>2012</year>
<volume>24</volume>
<issue>7</issue>
<fpage>1398</fpage>
<lpage>405</lpage>
<pub-id pub-id-type="doi">10.1016/j.cellsig.2012.03.001</pub-id>
<pub-id pub-id-type="pmid">22434044</pub-id>
</element-citation>
</ref>
<ref id="CR125">
<label>125.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mines</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Beurel</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Jope</surname>
<given-names>RS</given-names>
</name>
</person-group>
<article-title>Examination of methylphenidate-mediated behavior regulation by glycogen synthase kinase-3 in mice</article-title>
<source/>Eur J Pharmacol
          <year>2013</year>
<volume>698</volume>
<issue>1–3</issue>
<fpage>252</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1016/j.ejphar.2012.10.018</pub-id>
<pub-id pub-id-type="pmid">23099259</pub-id>
</element-citation>
</ref>
<ref id="CR126">
<label>126.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kahn</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Can we safely target the WNT pathway?</article-title>
<source/>Nat Rev Drug Discov
          <year>2014</year>
<volume>13</volume>
<issue>7</issue>
<fpage>513</fpage>
<lpage>32</lpage>
<pub-id pub-id-type="doi">10.1038/nrd4233</pub-id>
<pub-id pub-id-type="pmid">24981364</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>